<!DOCTYPE html>

<html class="client-nojs" dir="ltr" lang="en">
<head>
<meta charset="utf-8"/>
<title>Martin Shkreli - Wikipedia</title>
<script>document.documentElement.className = document.documentElement.className.replace( /(^|\s)client-nojs(\s|$)/, "$1client-js$2" );</script>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Martin_Shkreli","wgTitle":"Martin Shkreli","wgCurRevisionId":762047050,"wgRevisionId":762047050,"wgArticleId":33759585,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Pages containing links to subscription-only content","Wikipedia temporarily semi-protected biographies of living people","Use mdy dates from December 2015","Pages using infobox person with unknown parameters","Infobox person using ethnicity","Articles with hCards","Articles containing potentially dated statements from December 2015","All articles containing potentially dated statements","All articles with unsourced statements","Articles with unsourced statements from January 2017","Articles containing potentially dated statements from 2014","Articles with unsourced statements from August 2016","1983 births","2015 controversies","American chief executives","American hedge fund managers","American people of Albanian descent","American people of Croatian descent","Baruch College alumni","Chief executives in the pharmaceutical industry","ESports people","American company founders","Life sciences industry","Living people","People from Brooklyn","Wealth in the United States","Pricing controversies"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Martin_Shkreli","wgRelevantArticleId":33759585,"wgRequestId":"WIsjZQpAMFEAABd8sHEAAAJC","wgIsProbablyEditable":false,"wgRestrictionEdit":["autoconfirmed"],"wgRestrictionMove":[],"wgFlaggedRevsParams":{"tags":{}},"wgStableRevisionId":null,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgPreferredVariant":"en","wgMFDisplayWikibaseDescriptions":{"search":true,"nearby":true,"watchlist":true,"tagline":true},"wgRelatedArticles":null,"wgRelatedArticlesUseCirrusSearch":true,"wgRelatedArticlesOnlyUseCirrusSearch":false,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgCentralNoticeCookiesToDelete":[],"wgCentralNoticeCategoriesUsingLegacy":["Fundraising","fundraising"],"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgWikibaseItemId":"Q6776585","wgCentralAuthMobileDomain":false,"wgVisualEditorToolbarScrollOffset":0,"wgEditSubmitButtonLabelPublish":false});mw.loader.state({"ext.globalCssJs.user.styles":"ready","ext.globalCssJs.site.styles":"ready","site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","user.tokens":"loading","ext.math.styles":"ready","ext.cite.styles":"ready","wikibase.client.init":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","ext.wikimediaBadges":"ready","mediawiki.legacy.shared":"ready","mediawiki.legacy.commonPrint":"ready","mediawiki.sectionAnchor":"ready","mediawiki.skinning.interface":"ready","skins.vector.styles":"ready","ext.globalCssJs.user":"ready","ext.globalCssJs.site":"ready"});mw.loader.implement("user.options@0j3lz3q",function($,jQuery,require,module){mw.user.options.set({"variant":"en"});});mw.loader.implement("user.tokens@1dqfd7l",function ( $, jQuery, require, module ) {
mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});/*@nomin*/;

});mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","site","mediawiki.page.startup","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.legacy.wikibits","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.watchlist-notice","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.extra-toolbar-buttons","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.centralauth.centralautologin","mmv.head","mmv.bootstrap.autostart","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.navigationTiming","ext.uls.eventlogger","ext.uls.init","ext.uls.interface","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp","skins.vector.js"]);});</script>
<link href="/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.math.scripts%2Cstyles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<script async="" src="/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector"></script>
<meta content="" name="ResourceLoaderDynamicStyles"/>
<link href="/w/load.php?debug=false&amp;lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<meta content="MediaWiki 1.29.0-wmf.8" name="generator"/>
<meta content="origin-when-cross-origin" name="referrer"/>
<link href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Martin_Shkreli" rel="alternate"/>
<link href="/static/apple-touch/wikipedia.png" rel="apple-touch-icon"/>
<link href="/static/favicon/wikipedia.ico" rel="shortcut icon"/>
<link href="/w/opensearch_desc.php" rel="search" title="Wikipedia (en)" type="application/opensearchdescription+xml"/>
<link href="//en.wikipedia.org/w/api.php?action=rsd" rel="EditURI" type="application/rsd+xml"/>
<link href="//creativecommons.org/licenses/by-sa/3.0/" rel="copyright"/>
<link href="https://en.wikipedia.org/wiki/Martin_Shkreli" rel="canonical"/>
<link href="//login.wikimedia.org" rel="dns-prefetch"/>
<link href="//meta.wikimedia.org" rel="dns-prefetch"/>
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Martin_Shkreli rootpage-Martin_Shkreli skin-vector action-view"> <div class="noprint" id="mw-page-base"></div>
<div class="noprint" id="mw-head-base"></div>
<div class="mw-body" id="content" role="main">
<a id="top"></a>
<div id="siteNotice"><!-- CentralNotice --></div>
<div class="mw-indicators">
<div class="mw-indicator" id="mw-indicator-pp-default"><a href="/wiki/Wikipedia:Protection_policy#semi" title="This article is semi-protected until September 12, 2017, to promote compliance with the policy on biographies of living people"><img alt="Page semi-protected" data-file-height="128" data-file-width="128" height="20" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fc/Padlock-silver.svg/20px-Padlock-silver.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fc/Padlock-silver.svg/30px-Padlock-silver.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fc/Padlock-silver.svg/40px-Padlock-silver.svg.png 2x" width="20"/></a></div>
</div>
<h1 class="firstHeading" id="firstHeading" lang="en">Martin Shkreli</h1>
<div class="mw-body-content" id="bodyContent">
<div id="siteSub">From Wikipedia, the free encyclopedia</div>
<div id="contentSub"></div>
<div class="mw-jump" id="jump-to-nav">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
</div>
<div class="mw-content-ltr" dir="ltr" id="mw-content-text" lang="en"><script>function mfTempOpenSection(id){var block=document.getElementById("mf-section-"+id);block.className+=" open-block";block.previousSibling.className+=" open-block";}</script><table class="infobox biography vcard" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold"><span class="fn">Martin Shkreli</span></th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a class="image" href="/wiki/File:Martin_Shkreli_2016.jpg"><img alt="Martin Shkreli 2016.jpg" data-file-height="3840" data-file-width="3601" height="235" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/da/Martin_Shkreli_2016.jpg/220px-Martin_Shkreli_2016.jpg" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/da/Martin_Shkreli_2016.jpg/330px-Martin_Shkreli_2016.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/da/Martin_Shkreli_2016.jpg/440px-Martin_Shkreli_2016.jpg 2x" width="220"/></a>
<div>Shkreli testifying before the House Committee on Oversight and Government Reform, 2016</div>
</td>
</tr>
<tr>
<th scope="row">Born</th>
<td><span style="display:none">(<span class="bday">1983-04-01</span>)</span> April 1, 1983 <span class="noprint ForceAgeToShow">(age 33)</span><br/>
<span class="birthplace"><a href="/wiki/Brooklyn" title="Brooklyn">Brooklyn</a>, <a href="/wiki/New_York_City" title="New York City">New York City</a></span></td>
</tr>
<tr>
<th scope="row">Nationality</th>
<td class="category">American</td>
</tr>
<tr>
<th scope="row">Alma mater</th>
<td><a href="/wiki/Baruch_College" title="Baruch College">Baruch College</a></td>
</tr>
<tr>
<th scope="row">Occupation</th>
<td class="role">Corporate executive, <a href="/wiki/Hedge_fund" title="Hedge fund">hedge fund</a> manager, <a href="/wiki/Entrepreneurship" title="Entrepreneurship">entrepreneur</a>, livestreamer</td>
</tr>
<tr>
<th scope="row">Known for</th>
<td><a href="/wiki/Turing_Pharmaceuticals" title="Turing Pharmaceuticals">Turing Pharmaceuticals</a>; <a class="mw-redirect" href="/wiki/Retrophin" title="Retrophin">Retrophin</a></td>
</tr>
<tr>
<th scope="row">Criminal charge</th>
<td><a href="/wiki/Securities_fraud" title="Securities fraud">Securities fraud</a><sup class="reference" id="cite_ref-Matthews2015_1-0"><a href="#cite_note-Matthews2015-1">[1]</a></sup></td>
</tr>
</table>
<p><b>Martin Shkreli</b> (<span class="nowrap"><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English" title="Help:IPA for English">/<span style="border-bottom:1px dotted"><span title="/ˈ/ primary stress follows">ˈ</span><span title="/ʃ/ 'sh' in 'shy'">ʃ</span><span title="'k' in 'kind'">k</span><span title="'r' in 'rye'">r</span><span title="/ɛ/ short 'e' in 'bed'">ɛ</span><span title="'l' in 'lie'">l</span><span title="/i/ 'y' in 'happy'">i</span></span>/</a></span></span>, born 1983)<sup class="reference" id="cite_ref-McLean2015_3-0"><a href="#cite_note-McLean2015-3">[3]</a></sup> is an <a href="/wiki/United_States" title="United States">American</a> entrepreneur<sup class="reference" id="cite_ref-Creswell2015a_4-0"><a href="#cite_note-Creswell2015a-4">[4]</a></sup><sup class="reference" id="cite_ref-5"><a href="#cite_note-5">[5]</a></sup><sup class="reference" id="cite_ref-6"><a href="#cite_note-6">[6]</a></sup> and pharmaceutical executive.<sup class="reference" id="cite_ref-7"><a href="#cite_note-7">[7]</a></sup> He is co-founder of the <a href="/wiki/Hedge_fund" title="Hedge fund">hedge fund</a> MSMB Capital Management, co-founder and former <a href="/wiki/Chief_executive_officer" title="Chief executive officer">chief executive officer</a> (CEO) of the <a href="/wiki/Biotechnology" title="Biotechnology">biotechnology</a> firm <a class="mw-redirect" href="/wiki/Retrophin" title="Retrophin">Retrophin</a>, and founder and former CEO of <a href="/wiki/Turing_Pharmaceuticals" title="Turing Pharmaceuticals">Turing Pharmaceuticals</a>. In September 2015, Shkreli received widespread criticism when Turing obtained the manufacturing license for the <a href="/wiki/Antiparasitic" title="Antiparasitic">antiparasitic</a> drug <a class="mw-redirect" href="/wiki/Daraprim" title="Daraprim">Daraprim</a> and raised its price by a factor of 56 (from <a href="/wiki/United_States_dollar" title="United States dollar">US$</a>13.5 to <a href="/wiki/United_States_dollar" title="United States dollar">US$</a>750 per pill), leading him to be referred to by media as the "most hated man in America".<sup class="reference" id="cite_ref-Thomas2015_8-0"><a href="#cite_note-Thomas2015-8">[8]</a></sup></p>
<p>In December 2015, Shkreli was arrested by the <a href="/wiki/Federal_Bureau_of_Investigation" title="Federal Bureau of Investigation">FBI</a> after being indicted on <a href="/wiki/Federal_crime_in_the_United_States" title="Federal crime in the United States">federal charges</a> of <a href="/wiki/Securities_fraud" title="Securities fraud">securities fraud</a>. He is free on bail pending trial.<sup class="reference" id="cite_ref-Matthews2015_1-1"><a href="#cite_note-Matthews2015-1">[1]</a></sup><sup class="reference" id="cite_ref-Chung2015_9-0"><a href="#cite_note-Chung2015-9">[9]</a></sup> He resigned as CEO of Turing Pharmaceuticals and was replaced by the company's board chairman, Ron Tilles.<sup class="reference" id="cite_ref-Shkreli_quits_10-0"><a href="#cite_note-Shkreli_quits-10">[10]</a></sup><sup class="reference" id="cite_ref-11"><a href="#cite_note-11">[11]</a></sup><sup class="reference" id="cite_ref-12"><a href="#cite_note-12">[12]</a></sup></p>
<p></p>
<div class="toc" id="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Early_life"><span class="tocnumber">1</span> <span class="toctext">Early life</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Career"><span class="tocnumber">2</span> <span class="toctext">Career</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Hedge_funds_founded"><span class="tocnumber">2.1</span> <span class="toctext">Hedge funds founded</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Retrophin"><span class="tocnumber">2.2</span> <span class="toctext">Retrophin</span></a>
<ul>
<li class="toclevel-3 tocsection-5"><a href="#Thiola_price_hike_controversy"><span class="tocnumber">2.2.1</span> <span class="toctext">Thiola price hike controversy</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-6"><a href="#Turing_Pharmaceuticals"><span class="tocnumber">2.3</span> <span class="toctext">Turing Pharmaceuticals</span></a>
<ul>
<li class="toclevel-3 tocsection-7"><a href="#Daraprim_price_hike_controversy"><span class="tocnumber">2.3.1</span> <span class="toctext">Daraprim price hike controversy</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-8"><a href="#KaloBios_Pharmaceuticals"><span class="tocnumber">2.4</span> <span class="toctext">KaloBios Pharmaceuticals</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Criminal_prosecution"><span class="tocnumber">2.5</span> <span class="toctext">Criminal prosecution</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Testimony_before_Congress"><span class="tocnumber">2.6</span> <span class="toctext">Testimony before Congress</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-11"><a href="#Other_projects"><span class="tocnumber">3</span> <span class="toctext">Other projects</span></a></li>
<li class="toclevel-1 tocsection-12"><a href="#Personal_life"><span class="tocnumber">4</span> <span class="toctext">Personal life</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#Controversies"><span class="tocnumber">5</span> <span class="toctext">Controversies</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#References"><span class="tocnumber">6</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#External_links"><span class="tocnumber">7</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Early_life">Early life</span></h2>
<p>Shkreli was born in Coney Island Hospital, Brooklyn. He is the son of <a class="mw-redirect" href="/wiki/Albanian_American" title="Albanian American">Albanian</a> and <a href="/wiki/Croatian_Americans" title="Croatian Americans">Croatian</a> immigrants who worked as janitors.<sup class="reference" id="cite_ref-Ortiz2015_2-1"><a href="#cite_note-Ortiz2015-2">[2]</a></sup> He, his two sisters, and his brother grew up in a <a href="/wiki/Working_class_in_the_United_States" title="Working class in the United States">working class</a> community in <a href="/wiki/Sheepshead_Bay,_Brooklyn" title="Sheepshead Bay, Brooklyn">Sheepshead Bay, Brooklyn</a>.<sup class="reference" id="cite_ref-Thomas2015_8-1"><a href="#cite_note-Thomas2015-8">[8]</a></sup><sup class="reference" id="cite_ref-Pearson2015_13-0"><a href="#cite_note-Pearson2015-13">[13]</a></sup><sup class="reference" id="cite_ref-Gould2015_14-0"><a href="#cite_note-Gould2015-14">[14]</a></sup><sup class="reference" id="cite_ref-Creswell2015_15-0"><a href="#cite_note-Creswell2015-15">[15]</a></sup> Shkreli was raised <a class="mw-redirect" href="/wiki/Catholic" title="Catholic">Catholic</a> and attended Sunday school as a child.<sup class="reference" id="cite_ref-16"><a href="#cite_note-16">[16]</a></sup></p>
<p>Shkreli attended <a href="/wiki/Hunter_College_High_School" title="Hunter College High School">Hunter College High School</a>. He dropped out before his senior year due to a lack of interest,<sup class="reference" id="cite_ref-17"><a href="#cite_note-17">[17]</a></sup> but received the credits necessary for his diploma through a program that placed him in an internship at Wall Street hedge fund <a href="/wiki/Jim_Cramer" title="Jim Cramer">Cramer</a>, Berkowitz and Company<sup class="reference" id="cite_ref-Creswell2015_15-1"><a href="#cite_note-Creswell2015-15">[15]</a></sup> when he was 17.<sup class="reference" id="cite_ref-Thomas2015_8-2"><a href="#cite_note-Thomas2015-8">[8]</a></sup><sup class="reference" id="cite_ref-Pollack2015a_18-0"><a href="#cite_note-Pollack2015a-18">[18]</a></sup> Sources differ on whether Shkreli graduated from Hunter<sup class="reference" id="cite_ref-Pearson2015_13-1"><a href="#cite_note-Pearson2015-13">[13]</a></sup> or whether he received sufficient credits there but actually graduated from <a href="/wiki/City-As-School_High_School" title="City-As-School High School">City-As-School High School</a>.<sup class="reference" id="cite_ref-Chen2015_19-0"><a href="#cite_note-Chen2015-19">[19]</a></sup></p>
<p>Shkreli received a <a href="/wiki/Bachelor_of_Business_Administration" title="Bachelor of Business Administration">bachelor's degree in business administration</a> from <a href="/wiki/Baruch_College" title="Baruch College">Baruch College</a> in 2004.<sup class="reference" id="cite_ref-Thomas2015_8-3"><a href="#cite_note-Thomas2015-8">[8]</a></sup> Shkreli told <i><a href="/wiki/Vanity_Fair_(magazine)" title="Vanity Fair (magazine)">Vanity Fair</a></i> that he developed an interest in chemistry when a family member suffered from treatment-resistant <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">depression</a>.<sup class="reference" id="cite_ref-McLean2015_3-1"><a href="#cite_note-McLean2015-3">[3]</a></sup> In March 2015, Hunter College High School announced that Shkreli donated $1,000,000 to them.<sup class="reference" id="cite_ref-20"><a href="#cite_note-20">[20]</a></sup></p>
<h2><span class="mw-headline" id="Career">Career</span></h2>
<p>During Shkreli's time at Cramer, Berkowitz and Company, he recommended <a class="mw-redirect" href="/wiki/Short-selling" title="Short-selling">short-selling</a> a biotech stock, believing that the company's share price would drop. When it did so, Cramer's hedge fund profited. In 2003, <a class="mw-redirect" href="/wiki/Regeneron_Pharmaceuticals" title="Regeneron Pharmaceuticals">Regeneron Pharmaceuticals</a> was testing a weight‑loss drug, and Shkreli, then 19, predicted that the stock price would fall. Shkreli's prediction drew the attention of the <a class="mw-redirect" href="/wiki/Securities_and_Exchange_Commission" title="Securities and Exchange Commission">Securities and Exchange Commission</a>, which investigated Shkreli's knowledge about the stock but found no wrongdoing on his part.<sup class="reference" id="cite_ref-Barrett2014_21-0"><a href="#cite_note-Barrett2014-21">[21]</a></sup></p>
<h3><span class="mw-headline" id="Hedge_funds_founded">Hedge funds founded</span></h3>
<p>After four years as an associate at Cramer Berkowitz, Shkreli worked as an analyst for Intrepid Capital Management and <a href="/wiki/UBS" title="UBS">UBS</a> Wealth Management.<sup class="reference" id="cite_ref-22"><a href="#cite_note-22">[22]</a></sup> He then started his first hedge fund, Elea Capital Management, in 2006.<sup class="reference" id="cite_ref-Pollack2015a_18-1"><a href="#cite_note-Pollack2015a-18">[18]</a></sup><sup class="reference" id="cite_ref-nytindictment_23-0"><a href="#cite_note-nytindictment-23">[23]</a></sup> "In 2007, <a href="/wiki/Lehman_Brothers" title="Lehman Brothers">Lehman Brothers</a> sued Elea in New York state court for failing to cover a '<a href="/wiki/Put_option" title="Put option">put option</a> transaction' in which Shkreli bet the wrong way on a broad market decline. When stocks rose, Shkreli didn’t have the funds to make the bank whole. In October 2007, <a href="/wiki/Lehman_Brothers" title="Lehman Brothers">Lehman Brothers</a> won a $2.3 million default judgment against Shkreli and Elea", but <a href="/wiki/Bankruptcy_of_Lehman_Brothers" title="Bankruptcy of Lehman Brothers">Lehman collapsed</a> before it could collect on the ruling.<sup class="reference" id="cite_ref-Barrett2014_21-1"><a href="#cite_note-Barrett2014-21">[21]</a></sup></p>
<p>In September 2009, Shkreli launched MSMB Capital Management,<sup class="reference" id="cite_ref-Ortiz2015_2-2"><a href="#cite_note-Ortiz2015-2">[2]</a></sup><sup class="reference" id="cite_ref-24"><a href="#cite_note-24">[24]</a></sup> which took its name from the initials of the two founding portfolio managers, Shkreli and his childhood friend Marek Biestek.<sup class="reference" id="cite_ref-Pollack2015a_18-2"><a href="#cite_note-Pollack2015a-18">[18]</a></sup><sup class="reference" id="cite_ref-Barrett2014_21-2"><a href="#cite_note-Barrett2014-21">[21]</a></sup> Shkreli and Biestek shorted biotech companies, then described flaws in the companies on stock trading chat rooms.<sup class="reference" id="cite_ref-McLean2015_3-2"><a href="#cite_note-McLean2015-3">[3]</a></sup></p>
<p>On February 1, 2011, in a <a href="/wiki/Naked_short_selling" title="Naked short selling">naked short sale</a> on an account it held with <a href="/wiki/Merrill_Lynch" title="Merrill Lynch">Merrill Lynch</a>, MSMB Capital sold short 32 million shares of <a href="/wiki/Orexigen_Therapeutics" title="Orexigen Therapeutics">Orexigen Therapeutics</a> stock at about $2.50 per share the day after its price plunged from $9.09, when the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) declined to approve the drug <a href="/wiki/Bupropion/naltrexone" title="Bupropion/naltrexone">Contrave</a>.<sup class="reference" id="cite_ref-25"><a href="#cite_note-25">[25]</a></sup><sup class="reference" id="cite_ref-FBI2015_26-0"><a href="#cite_note-FBI2015-26">[26]</a></sup> The stock price rebounded; MSMB could not cover the position, although it had told Merrill Lynch that it could.<sup class="reference" id="cite_ref-27"><a href="#cite_note-27">[27]</a></sup> Merrill Lynch lost $7 million on the trade and MSMB Capital was virtually wiped out. Retrophin's 2015 SEC Complaint contended that Shkreli then created MSMB Healthcare and Retrophin "so that he could continue trading after MSMB Capital became insolvent and to create an asset that he might be able to use to placate his MSMB Capital investors."<sup class="reference" id="cite_ref-SEC_Court_Filing_28-0"><a href="#cite_note-SEC_Court_Filing-28">[28]</a></sup></p>
<p>In 2011, Shkreli filed requests with the FDA to reject a new cancer diagnostic device from Navidea Biopharmaceuticals and an inhalable <a href="/wiki/Insulin" title="Insulin">insulin</a> therapy from <a href="/wiki/MannKind_Corporation" title="MannKind Corporation">MannKind Corporation</a> while publicly short-selling both companies' stocks, the values of which dropped after Shkreli's interventions. The companies had difficulty launching the products as a result, although the FDA ultimately approved both.<sup class="reference" id="cite_ref-Barrett2014_21-3"><a href="#cite_note-Barrett2014-21">[21]</a></sup><sup class="reference" id="cite_ref-29"><a href="#cite_note-29">[29]</a></sup><sup class="reference" id="cite_ref-30"><a href="#cite_note-30">[30]</a></sup></p>
<p>In 2011, MSMB made an unsolicited cash bid for AMAG Pharmaceuticals, <a href="/wiki/United_States_dollar" title="United States dollar">US$</a>378,000,000.<sup class="reference" id="cite_ref-31"><a href="#cite_note-31">[31]</a></sup> Matthew Herper of <i><a href="/wiki/Forbes" title="Forbes">Forbes</a></i> wrote that the attempted hostile takeover was "done for the specific purpose of firing the company’s management and stopping a proposed merger with Allos Therapeutics. When the merger plans stopped, so did Shkreli."<sup class="reference" id="cite_ref-32"><a href="#cite_note-32">[32]</a></sup></p>
<h3><span class="mw-headline" id="Retrophin">Retrophin</span></h3>
<p>Shkreli founded Retrophin (a <a href="/wiki/Portmanteau" title="Portmanteau">portmanteau</a> of "recombinant <a href="/wiki/Dystrophin" title="Dystrophin">dystrophin</a>") in 2011 under the MSMB umbrella, and ran it as a portfolio company with an emphasis on biotechnology, to create treatments for <a href="/wiki/Rare_disease" title="Rare disease">rare diseases</a>.<sup class="reference" id="cite_ref-Barrett2014_21-4"><a href="#cite_note-Barrett2014-21">[21]</a></sup><sup class="reference" id="cite_ref-33"><a href="#cite_note-33">[33]</a></sup><sup class="reference" id="cite_ref-34"><a href="#cite_note-34">[34]</a></sup><sup class="reference" id="cite_ref-Retrophin_35-0"><a href="#cite_note-Retrophin-35">[35]</a></sup></p>
<p>Retrophin's board decided to replace Shkreli in September 2014, and he resigned from the company the following month.<sup class="reference" id="cite_ref-SEC_Court_Filing_28-1"><a href="#cite_note-SEC_Court_Filing-28">[28]</a></sup> He was replaced by Stephen Aselage.<sup class="reference" id="cite_ref-36"><a href="#cite_note-36">[36]</a></sup> During Shkreli's tenure as CEO, the company's employees used alias Twitter accounts to make gangster rap jokes and encourage short selling of other biotech stocks.<sup class="reference" id="cite_ref-37"><a href="#cite_note-37">[37]</a></sup> Critics argued that Shkreli was intelligent but too immature and unfocused for the job of CEO.<sup class="reference" id="cite_ref-38"><a href="#cite_note-38">[38]</a></sup></p>
<p>After Shkreli's departure, Retrophin filed a <span style="white-space: nowrap">US$65 million</span> lawsuit against him in August 2015, claiming that he had breached his duty of loyalty to the biopharmaceutical company in a long-running dispute over his use of company funds<sup class="reference" id="cite_ref-SEC_Court_Filing_28-2"><a href="#cite_note-SEC_Court_Filing-28">[28]</a></sup><sup class="reference" id="cite_ref-39"><a href="#cite_note-39">[39]</a></sup><sup class="reference" id="cite_ref-40"><a href="#cite_note-40">[40]</a></sup> and "committed stock-trading irregularities and other violations of securities rules".<sup class="reference" id="cite_ref-41"><a href="#cite_note-41">[41]</a></sup> The lawsuit alleged that Shkreli had threatened and harassed a former MSMB employee and his family.<sup class="reference" id="cite_ref-42"><a href="#cite_note-42">[42]</a></sup> Shkreli and some of his business associates have been under criminal investigation by the <a class="mw-redirect" href="/wiki/U.S._Attorney_for_the_Eastern_District_of_New_York" title="U.S. Attorney for the Eastern District of New York">U.S. Attorney for the Eastern District of New York</a> since January 2015. Shkreli invoked his <a href="/wiki/Fifth_Amendment_to_the_United_States_Constitution" title="Fifth Amendment to the United States Constitution">Fifth Amendment</a> right against <a href="/wiki/Self-incrimination" title="Self-incrimination">self-incrimination</a> in order to avoid testifying during civil depositions.<sup class="reference" id="cite_ref-NW20150927_43-0"><a href="#cite_note-NW20150927-43">[43]</a></sup><sup class="reference" id="cite_ref-44"><a href="#cite_note-44">[44]</a></sup></p>
<p>Shkreli's name is on two patents held by Retrophin for drugs to treat <a href="/wiki/Pantothenate_kinase-associated_neurodegeneration" title="Pantothenate kinase-associated neurodegeneration">PKAN</a>.<sup class="reference" id="cite_ref-McLean2015_3-3"><a href="#cite_note-McLean2015-3">[3]</a></sup><sup class="reference" id="cite_ref-45"><a href="#cite_note-45">[45]</a></sup></p>
<h4><span class="mw-headline" id="Thiola_price_hike_controversy">Thiola price hike controversy</span></h4>
<p>In May 2014 Retrophin acquired the rights to market <a class="mw-redirect" href="/wiki/Thiola" title="Thiola">Thiola</a>, a drug used to treat the rare disease <a href="/wiki/Cystinuria" title="Cystinuria">cystinuria</a>.<sup class="reference" id="cite_ref-Allen2015_46-0"><a href="#cite_note-Allen2015-46">[46]</a></sup> Shortly before Retrophin fired Shkreli, Retrophin raised the price of Thiola from $1.50 to $30 per pill; patients must take 10 to 15 pills a day.<sup class="reference" id="cite_ref-imprimis_47-0"><a href="#cite_note-imprimis-47">[47]</a></sup> In an article titled "The Most Unconscionable Drug Price Hike I Have Yet Seen", <a class="mw-redirect" href="/wiki/Medicinal_chemist" title="Medicinal chemist">medicinal chemist</a> <a href="/wiki/Derek_Lowe_(chemist)" title="Derek Lowe (chemist)">Derek Lowe</a> wrote of the Thiola action, "This one enrages me, and I do drug research for a living".<sup class="reference" id="cite_ref-48"><a href="#cite_note-48">[48]</a></sup> Retrophin did not lower the price after Shkreli's departure.<sup class="reference" id="cite_ref-49"><a href="#cite_note-49">[49]</a></sup> In February 2016 <a href="/wiki/Imprimis_Pharmaceuticals" title="Imprimis Pharmaceuticals">Imprimis Pharmaceuticals</a> announced it had developed a lower-cost alternative to Thiola<sup class="reference" id="cite_ref-imprimis_47-1"><a href="#cite_note-imprimis-47">[47]</a></sup> and in May 2016 began selling two formulations of it.<sup class="reference" id="cite_ref-50"><a href="#cite_note-50">[50]</a></sup></p>
<h3><span class="mw-headline" id="Turing_Pharmaceuticals">Turing Pharmaceuticals</span></h3>
<p>Shkreli founded <a href="/wiki/Turing_Pharmaceuticals" title="Turing Pharmaceuticals">Turing Pharmaceuticals</a> in February 2015, after his departure from Retrophin. He launched Turing with three drugs in development acquired from Retrophin: an <a class="mw-redirect" href="/wiki/Intranasal" title="Intranasal">intranasal</a> version of <a href="/wiki/Ketamine" title="Ketamine">ketamine</a> for depression, an intranasal version of <a href="/wiki/Oxytocin" title="Oxytocin">oxytocin</a>, and <a class="mw-redirect" href="/wiki/Vecamyl" title="Vecamyl">Vecamyl</a> for <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>.<sup class="reference" id="cite_ref-51"><a href="#cite_note-51">[51]</a></sup> Shkreli set a business strategy for Turing: to obtain licenses on out-of-<a href="/wiki/Patent" title="Patent">patent</a> medicines and reevaluate the pricing of each in pursuit of <a class="mw-redirect" href="/wiki/Windfall_profit" title="Windfall profit">windfall profits</a> for the new company, without the need to develop and bring its own drugs to market.<sup class="reference" id="cite_ref-Surowiecki151012_52-0"><a href="#cite_note-Surowiecki151012-52">[52]</a></sup><sup class="reference" id="cite_ref-Lowe2015_53-0"><a href="#cite_note-Lowe2015-53">[53]</a></sup> As markets for out-of-patent drugs are often small, and obtaining regulatory approval to manufacture a generic version is expensive, Turing calculated that with closed distribution for the product and no competition, it could set high prices.<sup class="reference" id="cite_ref-Surowiecki151012_52-1"><a href="#cite_note-Surowiecki151012-52">[52]</a></sup></p>
<h4><span class="mw-headline" id="Daraprim_price_hike_controversy">Daraprim price hike controversy</span></h4>
<p>In accordance with Shkreli's business plan, Turing acquired Daraprim (<a href="/wiki/Pyrimethamine" title="Pyrimethamine">pyrimethamine</a>), a medication approved by the FDA in 1953,<sup class="reference" id="cite_ref-54"><a href="#cite_note-54">[54]</a></sup> for <span style="white-space: nowrap">US$55 million</span>.<sup class="reference" id="cite_ref-NBCSpark_55-0"><a href="#cite_note-NBCSpark-55">[55]</a></sup><sup class="reference" id="cite_ref-56"><a href="#cite_note-56">[56]</a></sup> on August 10, 2015, from <a href="/wiki/Impax_Laboratories" title="Impax Laboratories">Impax Laboratories</a>.<sup class="reference" id="cite_ref-TimmermanForbes150923_57-0"><a href="#cite_note-TimmermanForbes150923-57">[57]</a></sup> The drug's most prominent use as of late 2015 was as an <a class="mw-redirect" href="/wiki/Malaria_drugs" title="Malaria drugs">anti-malarial</a><sup class="reference" id="cite_ref-NYTOvernight_58-0"><a href="#cite_note-NYTOvernight-58">[58]</a></sup> and an <a class="mw-redirect" href="/wiki/Antiparasitic_drug" title="Antiparasitic drug">antiparasitic</a>, in conjunction with <a class="mw-redirect" href="/wiki/Leucovorin" title="Leucovorin">leucovorin</a> and <a href="/wiki/Sulfadiazine" title="Sulfadiazine">sulfadiazine</a><sup class="reference" id="cite_ref-PMID24585567_59-0"><a href="#cite_note-PMID24585567-59">[59]</a></sup> to treat patients with AIDS-related and AIDS-unrelated <a href="/wiki/Toxoplasmosis" title="Toxoplasmosis">toxoplasmosis</a>.<sup class="reference" id="cite_ref-MuoioHelio150917_60-0"><a href="#cite_note-MuoioHelio150917-60">[60]</a></sup> The <a class="mw-redirect" href="/wiki/Pharmaceutical_patent" title="Pharmaceutical patent">patent</a> for Daraprim had expired, but no <a href="/wiki/Generic_drug" title="Generic drug">generic</a> version was available.<sup class="reference" id="cite_ref-61"><a href="#cite_note-61">[61]</a></sup> The Turing–Impax deal included the condition that Impax remove the drug from regular wholesalers and pharmacies,<sup class="reference" id="cite_ref-NYTOvernight_58-1"><a href="#cite_note-NYTOvernight-58">[58]</a></sup> and so in June 2015, two months before the sale to Turing was announced, Impax switched to tightly controlled distribution.<sup class="reference" id="cite_ref-Pollack2015a_18-3"><a href="#cite_note-Pollack2015a-18">[18]</a></sup> In keeping with its strategy for pricing in the face of limited competition (see above), Turing maintained the closed distribution.<sup class="reference" id="cite_ref-Surowiecki151012_52-2"><a href="#cite_note-Surowiecki151012-52">[52]</a></sup> The <i><a class="mw-redirect" href="/wiki/New_York_Times" title="New York Times">New York Times</a></i> noted that the deal "made sense only if Turing planned to raise the price of the drug substantially."<sup class="reference" id="cite_ref-Pollack2015a_18-4"><a href="#cite_note-Pollack2015a-18">[18]</a></sup></p>
<p>On September 17, 2015, Dave Muoio of <i>Healio</i>, an in-depth clinical information website for health care specialists,<sup class="reference" id="cite_ref-HealioExpln_62-0"><a href="#cite_note-HealioExpln-62">[62]</a></sup> reported on a letter from the <a href="/wiki/Infectious_Diseases_Society_of_America" title="Infectious Diseases Society of America">Infectious Diseases Society of America</a> and the HIV Medicine Association to executives at Turing,<sup class="reference" id="cite_ref-hivma_63-0"><a href="#cite_note-hivma-63">[63]</a></sup> questioning a new pricing for Daraprim.<sup class="reference" id="cite_ref-MuoioHelio150917_60-1"><a href="#cite_note-MuoioHelio150917-60">[60]</a></sup> The price of a dose of the drug in the U.S. market increased from <span style="white-space: nowrap">US$13.50</span> to <span style="white-space: nowrap">US$750</span> per pill, overnight, a factor of 56.<sup class="reference" id="cite_ref-CorrectPercent_64-0"><a href="#cite_note-CorrectPercent-64">[64]</a></sup></p>
<p>The price increase was initially criticized, jointly, by the <a href="/wiki/Infectious_Diseases_Society_of_America" title="Infectious Diseases Society of America">Infectious Diseases Society of America</a> and the <a class="new" href="/w/index.php?title=HIV_Medicine_Association&amp;action=edit&amp;redlink=1" title="HIV Medicine Association (page does not exist)">HIV Medicine Association</a>,<sup class="reference" id="cite_ref-NYTOvernight_58-2"><a href="#cite_note-NYTOvernight-58">[58]</a></sup><sup class="reference" id="cite_ref-hivma_63-1"><a href="#cite_note-hivma-63">[63]</a></sup> by the <a href="/wiki/Pharmaceutical_Research_and_Manufacturers_of_America" title="Pharmaceutical Research and Manufacturers of America">Pharmaceutical Research and Manufacturers of America</a>,<sup class="reference" id="cite_ref-BloombergTargeted_65-0"><a href="#cite_note-BloombergTargeted-65">[65]</a></sup> and soon thereafter by <a href="/wiki/United_States_presidential_election,_2016" title="United States presidential election, 2016">presidential candidates</a> <a href="/wiki/Hillary_Clinton" title="Hillary Clinton">Hillary Clinton</a>,<sup class="reference" id="cite_ref-CNNMeet_66-0"><a href="#cite_note-CNNMeet-66">[66]</a></sup> <a href="/wiki/Bernie_Sanders" title="Bernie Sanders">Bernie Sanders</a>,<sup class="reference" id="cite_ref-WaPoMoron_67-0"><a href="#cite_note-WaPoMoron-67">[67]</a></sup> and <a href="/wiki/Donald_Trump" title="Donald Trump">Donald Trump</a>.<sup class="reference" id="cite_ref-trump_bi_68-0"><a href="#cite_note-trump_bi-68">[68]</a></sup> A subsequent organized effort called on Turing to return pricing to pre-September levels and to address several matters relating to the needs of patients, an effort that garnered endorsements from more than 160 medical‑specialty and patient‑related organizations (as of December 2015<sup class="plainlinks noprint asof-tag update" style="display:none;"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Martin_Shkreli&amp;action=edit">[update]</a></sup>, 164 organizations from thirty-one states, the <a class="mw-redirect" href="/wiki/District_of_Columbia" title="District of Columbia">District of Columbia</a>, and <a href="/wiki/Puerto_Rico" title="Puerto Rico">Puerto Rico</a>).<sup class="reference" id="cite_ref-69"><a href="#cite_note-69">[69]</a></sup><sup class="reference" id="cite_ref-IDSAopenLttr_70-0"><a href="#cite_note-IDSAopenLttr-70">[70]</a></sup></p>
<p>In response to the controversy, the record label <a class="mw-redirect" href="/wiki/Collect_Records" title="Collect Records">Collect Records</a> publicly ended its business relationship with Shkreli, who had invested in the company.<sup class="reference" id="cite_ref-71"><a href="#cite_note-71">[71]</a></sup></p>
<p>In a September 2015 interview with <i><a href="/wiki/Bloomberg_Markets" title="Bloomberg Markets">Bloomberg Markets</a></i>, Shkreli claimed that despite the price increase, patient co-pays would actually be lower, that many patients would get the drug at no cost, that Turing had expanded its free drug program, and that it sold half of its drugs for one dollar.<sup class="reference" id="cite_ref-Fu2015_72-0"><a href="#cite_note-Fu2015-72">[72]</a></sup> He defended the price hike by saying, "If there was a company that was selling an Aston Martin at the price of a bicycle, and we buy that company and we ask to charge Toyota prices, I don’t think that that should be a crime."<sup class="reference" id="cite_ref-Ramsey_Aston_Martin_73-0"><a href="#cite_note-Ramsey_Aston_Martin-73">[73]</a></sup><sup class="reference" id="cite_ref-Aston_Martin_Reuters_74-0"><a href="#cite_note-Aston_Martin_Reuters-74">[74]</a></sup> A few days later, Shkreli announced that he planned to lower the price by an unspecified amount, "in response to the anger that was felt by people".<sup class="reference" id="cite_ref-NW20150927_43-1"><a href="#cite_note-NW20150927-43">[43]</a></sup> But in late November, Turing reversed course and said it would not lower the price after all.<sup class="reference" id="cite_ref-Pollack2015b_75-0"><a href="#cite_note-Pollack2015b-75">[75]</a></sup> Following a request by Senator Bernie Sanders and Representative <a href="/wiki/Elijah_Cummings" title="Elijah Cummings">Elijah Cummings</a> for details of Turing Pharmaceuticals' finances and price-setting practices in September 2015,<sup class="reference" id="cite_ref-76"><a href="#cite_note-76">[76]</a></sup><sup class="reference" id="cite_ref-77"><a href="#cite_note-77">[77]</a></sup> the company hired four <a class="mw-redirect" href="/wiki/Lobbyist" title="Lobbyist">lobbyists</a> from <a href="/wiki/Buchanan,_Ingersoll_%26_Rooney" title="Buchanan, Ingersoll &amp; Rooney">Buchanan, Ingersoll &amp; Rooney</a> with backgrounds in health care legislation and pharmaceutical pricing.<sup class="reference" id="cite_ref-78"><a href="#cite_note-78">[78]</a></sup><sup class="reference" id="cite_ref-Ho2015_79-0"><a href="#cite_note-Ho2015-79">[79]</a></sup> In addition to the lobbyists, Shkreli hired a crisis public relations firm to help explain the pricing decision.<sup class="reference" id="cite_ref-Martin_Shkreli-Ripp_80-0"><a href="#cite_note-Martin_Shkreli-Ripp-80">[80]</a></sup></p>
<p>On October 22, 2015, <a class="mw-redirect" href="/wiki/Mark_Baum" title="Mark Baum">Mark Baum</a>, CEO of <a href="/wiki/Imprimis_Pharmaceuticals" title="Imprimis Pharmaceuticals">Imprimis Pharmaceuticals</a>, announced that his company would provide a combination product containing pyrimethamine (the active ingredient in Daraprim) and leucovorin at "$1-a-pill" as a cheaper and more efficient alternative to Daraprim.<sup class="reference" id="cite_ref-FoxMaggieNBC151022_81-0"><a href="#cite_note-FoxMaggieNBC151022-81">[81]</a></sup> This product is intended to be used alongside sulfadiazine in the standard protocol to treat <a href="/wiki/Toxoplasmosis" title="Toxoplasmosis">toxoplasmosis</a> typically seen in <a class="mw-redirect" href="/wiki/AIDS" title="AIDS">AIDS</a> patients.<sup class="reference" id="cite_ref-MuoioHelio150917_60-2"><a href="#cite_note-MuoioHelio150917-60">[60]</a></sup></p>
<p>Baum noted, "This is not the first time a sole supply generic drug – especially one that has been approved for use as long as Daraprim – has had its price increased suddenly and to a level that may make it unaffordable". He announced the availability of the compounded replacement for Daraprim as a part of a larger corporate program, "Imprimis Cares", to make "novel and customizable medicines available to physicians and patients at accessible prices". Imprimis is now offering its compounded, orally taken formulations of pyrimethamine and leucovorin beginning at <span style="white-space: nowrap">US$99</span> for a 100‑count bottle, essentially a dollar a dose.<sup class="reference" id="cite_ref-FoxMaggieNBC151022_81-1"><a href="#cite_note-FoxMaggieNBC151022-81">[81]</a></sup></p>
<p>On November 23, 2015, Turing announced that the company would not reduce the <a href="/wiki/List_price" title="List price">list price</a> of Daraprim, but said it planned instead to negotiate volume discounts of up to 50% for hospitals.<sup class="reference" id="cite_ref-82"><a href="#cite_note-82">[82]</a></sup> Turing said it was not as important to cut the list price as to reduce the cost to hospitals, where most patients get their initial treatment. The company pledged that no patient needing Daraprim would ever be denied access.<sup class="reference" id="cite_ref-Pollack2015b_75-1"><a href="#cite_note-Pollack2015b-75">[75]</a></sup> Infectious disease specialists and patient advocates, including Tim Horn of the <a href="/wiki/Treatment_Action_Group" title="Treatment Action Group">Treatment Action Group</a> and Carlos del Rio of the HIV Medicine Association, said Turing's actions were insufficient, given that patients initially treated for days at a hospital typically have to continue the treatment for weeks or months after leaving.<sup class="reference" id="cite_ref-83"><a href="#cite_note-83">[83]</a></sup></p>
<h3><span class="mw-headline" id="KaloBios_Pharmaceuticals">KaloBios Pharmaceuticals</span></h3>
<p>In November 2015, an investor group led by Shkreli acquired a majority stake in KaloBios Pharmaceuticals (<a href="/wiki/OTC_Markets_Group" title="OTC Markets Group">OTC Pink</a> Limited: <a class="external text" href="http://www.otcmarkets.com/stock/KBIOQ/quote" rel="nofollow">KBIOQ</a>), a <a href="/wiki/Biopharmaceutical" title="Biopharmaceutical">biopharmaceutical</a> company based in <a href="/wiki/South_San_Francisco,_California" title="South San Francisco, California">South San Francisco, California</a>.<sup class="reference" id="cite_ref-84"><a href="#cite_note-84">[84]</a></sup> Shkreli was named CEO of the company and also planned to continue in the role of CEO of Turing Pharmaceuticals.<sup class="reference" id="cite_ref-85"><a href="#cite_note-85">[85]</a></sup><sup class="reference" id="cite_ref-86"><a href="#cite_note-86">[86]</a></sup> After his December 2015 arrest, KaloBios Pharmaceuticals terminated him as CEO.<sup class="reference" id="cite_ref-87"><a href="#cite_note-87">[87]</a></sup> On December 29, 2015, KaloBios filed for <a class="mw-redirect" href="/wiki/Chapter_11" title="Chapter 11">Chapter 11</a> bankruptcy. This followed <a href="/wiki/NASDAQ" title="NASDAQ">NASDAQ</a> delisting its shares, and the resignation of two directors.<sup class="reference" id="cite_ref-cnbc-chap-11_88-0"><a href="#cite_note-cnbc-chap-11-88">[88]</a></sup></p>
<h3><span class="mw-headline" id="Criminal_prosecution">Criminal prosecution</span></h3>
<p>On December 17, 2015, Shkreli was arrested by the <a href="/wiki/Federal_Bureau_of_Investigation" title="Federal Bureau of Investigation">FBI</a> after a federal <a href="/wiki/Indictment" title="Indictment">indictment</a><sup class="reference" id="cite_ref-89"><a href="#cite_note-89">[89]</a></sup> in the <a class="mw-redirect" href="/wiki/U.S._District_Court_for_the_Eastern_District_of_New_York" title="U.S. District Court for the Eastern District of New York">U.S. District Court for the Eastern District of New York</a> was filed, charging him with <a href="/wiki/Securities_fraud" title="Securities fraud">securities fraud</a>. The charges were filed after an investigation into his tenure at MSMB Capital Management and Retrophin. He was accused of running a <a href="/wiki/Ponzi_scheme" title="Ponzi scheme">Ponzi</a>-like scheme.<sup class="reference" id="cite_ref-Matthews2015_1-2"><a href="#cite_note-Matthews2015-1">[1]</a></sup> A <a href="/wiki/United_States_Department_of_Justice" title="United States Department of Justice">United States Department of Justice</a> press release said, "As alleged, Martin Shkreli engaged in multiple schemes to ensnare investors through a web of lies and deceit".<sup class="reference" id="cite_ref-90"><a href="#cite_note-90">[90]</a></sup><sup class="reference" id="cite_ref-Grim2015_91-0"><a href="#cite_note-Grim2015-91">[91]</a></sup> In an interview with <i>The Wall Street Journal</i>, Shkreli said that he was targeted by law enforcement for his price hikes of the drug <a class="mw-redirect" href="/wiki/Daraprim" title="Daraprim">Daraprim</a> and his flamboyant personality.<sup class="reference" id="cite_ref-Copeland2015_92-0"><a href="#cite_note-Copeland2015-92">[92]</a></sup></p>
<p>In his nationally syndicated column, political commentator <a href="/wiki/Robert_Reich" title="Robert Reich">Robert Reich</a> wrote that what Shkreli did wrong was to be more audacious while "play[ing] the same game many others are playing on Wall<span class="nowrap"> </span>Street and in corporate suites".<sup class="reference" id="cite_ref-Reich2015_93-0"><a href="#cite_note-Reich2015-93">[93]</a></sup></p>
<p>In early 2016, Shkreli retained <a class="mw-redirect" href="/wiki/Criminal_defense_attorney" title="Criminal defense attorney">criminal defense attorney</a> <a href="/wiki/Benjamin_Brafman" title="Benjamin Brafman">Benjamin Brafman</a> to defend him.<sup class="reference" id="cite_ref-Goldstein2016_94-0"><a href="#cite_note-Goldstein2016-94">[94]</a></sup><sup class="reference" id="cite_ref-Silverstein2016_95-0"><a href="#cite_note-Silverstein2016-95">[95]</a></sup></p>
<h3><span class="mw-headline" id="Testimony_before_Congress">Testimony before Congress</span></h3>
<p>Shkreli was <a href="/wiki/Subpoena" title="Subpoena">subpoenaed</a> to appear before the <a href="/wiki/United_States_House_Committee_on_Oversight_and_Government_Reform" title="United States House Committee on Oversight and Government Reform">Committee on Oversight and Government Reform</a> of the <a href="/wiki/United_States_House_of_Representatives" title="United States House of Representatives">U.S. House of Representatives</a> to answer questions about the Daraprim price increase.<sup class="reference" id="cite_ref-JohnsonWaPo_96-0"><a href="#cite_note-JohnsonWaPo-96">[96]</a></sup> Shkreli's efforts to quash the subpoena were unsuccessful.<sup class="reference" id="cite_ref-JohnsonWaPo_96-1"><a href="#cite_note-JohnsonWaPo-96">[96]</a></sup></p>
<p>On February 4, 2016, Shkreli appeared before the House committee,<sup class="reference" id="cite_ref-97"><a href="#cite_note-97">[97]</a></sup> along with Nancy Retzlaff,<sup class="reference" id="cite_ref-98"><a href="#cite_note-98">[98]</a></sup> the Chief Commercial Officer of Turing, and Howard B. Schiller, the interim CEO of <a href="/wiki/Valeant_Pharmaceuticals" title="Valeant Pharmaceuticals">Valeant</a>.<sup class="reference" id="cite_ref-99"><a href="#cite_note-99">[99]</a></sup></p>
<p>Shkreli followed his <a href="/wiki/Counsel" title="Counsel">lawyer</a>'s advice and refused to answer all questions with exception to the question pertaining to his name by South Carolina Congressman Trey Gowdy<sup class="reference" id="cite_ref-100"><a href="#cite_note-100">[100]</a></sup><sup class="reference" id="cite_ref-101"><a href="#cite_note-101">[101]</a></sup> – including those related to his acquisition of the most expensive music album ever made<sup class="reference" id="cite_ref-Leonard2015_102-0"><a href="#cite_note-Leonard2015-102">[102]</a></sup> – by exercising his <a href="/wiki/Fifth_Amendment_to_the_United_States_Constitution" title="Fifth Amendment to the United States Constitution">Fifth Amendment</a> rights.<sup class="reference" id="cite_ref-Pollack2016_103-0"><a href="#cite_note-Pollack2016-103">[103]</a></sup> On the same day, Shkreli wrote a public message on <a href="/wiki/Twitter" title="Twitter">Twitter</a> reading, "Hard to accept that these imbeciles represent the people in our government",<sup class="reference" id="cite_ref-JohnsonWaPo_96-2"><a href="#cite_note-JohnsonWaPo-96">[96]</a></sup> and later he took to the internet saying he was willing to take questions from the public that he’d refused to answer before Congress, justifying his position by accusing the Congressmen of being motivated purely by “self-interest.”<sup class="reference" id="cite_ref-104"><a href="#cite_note-104">[104]</a></sup></p>
<h2><span class="mw-headline" id="Other_projects">Other projects</span></h2>
<p>Shkreli is a <i><a href="/wiki/League_of_Legends" title="League of Legends">League of Legends</a></i> player and in May 2014 he began expressing interest in purchasing an <a href="/wiki/ESports" title="ESports">eSports</a> team,<sup class="reference" id="cite_ref-105"><a href="#cite_note-105">[105]</a></sup> <a class="mw-redirect" href="/wiki/Enemy_eSports" title="Enemy eSports">Enemy eSports</a> announced that it had rejected a <span style="white-space: nowrap">US$1.2 million</span> offer from Shkreli.<sup class="reference" id="cite_ref-106"><a href="#cite_note-106">[106]</a></sup> He later founded his own team, Odyssey eSports, and aimed to qualify for the 2015 <a class="mw-redirect" href="/wiki/North_American_League_of_Legends_Challenger_Series" title="North American League of Legends Challenger Series">North American League of Legends Challenger Series</a>. The team failed to qualify. In August 2015, Odyssey merged with another team to become the organisation Team Imagine, with Shkreli becoming chairman of the team. During the merger, the organisation signed the <i><a href="/wiki/Dota_2" title="Dota 2">Dota 2</a></i> team Leviathan.<sup class="reference" id="cite_ref-107"><a href="#cite_note-107">[107]</a></sup><sup class="reference" id="cite_ref-108"><a href="#cite_note-108">[108]</a></sup></p>
<p>In November 2015, Shkreli began <a href="/wiki/Streaming_media" title="Streaming media">livestreaming</a> on <a href="/wiki/YouTube" title="YouTube">YouTube</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (January 2017)">citation needed</span></a></i>]</sup> His streams, which last for hours at a time, have shown him working and <a href="/wiki/Idle" title="Idle">idly</a> passing time in mundane ways, such as playing <a href="/wiki/Video_game" title="Video game">video games</a>, using social media or taking <a href="/wiki/Telephone_call" title="Telephone call">telephone calls</a>.<sup class="reference" id="cite_ref-109"><a href="#cite_note-109">[109]</a></sup> Later he started a financial and chemistry class explaining the basics of each subject.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (January 2017)">citation needed</span></a></i>]</sup> Shkreli had previously streamed on the website <a href="/wiki/Twitch.tv" title="Twitch.tv">Twitch</a> but switched to YouTube. <sup class="reference" id="cite_ref-110"><a href="#cite_note-110">[110]</a></sup> When Shkreli was <a href="/wiki/Arraignment" title="Arraignment">arraigned</a> in December and released on bail, he continued streaming from his apartment.<sup class="reference" id="cite_ref-111"><a href="#cite_note-111">[111]</a></sup></p>
<p>Shkreli was formerly a benefactor of <a class="mw-redirect" href="/wiki/Collect_Records" title="Collect Records">Collect Records</a> and offered to bail out <a href="/wiki/Bobby_Shmurda" title="Bobby Shmurda">Bobby Shmurda</a>; Shkreli abandoned this after his own arrest.<sup class="reference" id="cite_ref-112"><a href="#cite_note-112">[112]</a></sup><sup class="reference" id="cite_ref-113"><a href="#cite_note-113">[113]</a></sup></p>
<h2><span class="mw-headline" id="Personal_life">Personal life</span></h2>
<p>As of 2014<sup class="plainlinks noprint asof-tag update" style="display:none;"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Martin_Shkreli&amp;action=edit">[update]</a></sup>, Shkreli had served as chair of the board of the <a href="/wiki/National_Albanian_American_Council" title="National Albanian American Council">National Albanian American Council</a> since 2008.<sup class="reference" id="cite_ref-Bojku2014_114-0"><a href="#cite_note-Bojku2014-114">[114]</a></sup></p>
<p>In October 2015, presidential candidate <a href="/wiki/Bernie_Sanders" title="Bernie Sanders">Bernie Sanders</a> acknowledged having received a $2,700 donation from Shkreli, whom he had previously called a "poster child of greed". Sanders, however, said he would forward the money to <a href="/wiki/Whitman-Walker_Health" title="Whitman-Walker Health">Whitman-Walker Health</a>, a D.C. community clinic known for its expertise in <a href="/wiki/HIV/AIDS" title="HIV/AIDS">HIV/AIDS</a> healthcare. Shkreli told medicine news portal STAT amongst his reasons to donate to Senator Sanders' campaign is that he does support some of his policies, just not the ones about drug prices. Mainly he hoped to raise Sanders' attention in order to explain to him in a private meeting the drug companies' price setting mechanisms.<sup class="reference" id="cite_ref-115"><a href="#cite_note-115">[115]</a></sup></p>
<p>Shkreli was revealed as the winner of an auction for the <a href="/wiki/Wu-Tang_Clan" title="Wu-Tang Clan">Wu-Tang Clan</a> album <i><a href="/wiki/Once_Upon_a_Time_in_Shaolin" title="Once Upon a Time in Shaolin">Once Upon a Time in Shaolin</a></i> after the single copy of the album was sold via <a href="/wiki/Paddle8" title="Paddle8">Paddle8</a> on November 24, 2015, for <span style="white-space: nowrap">US$2 million</span> to what was reported to be a "private American collector".<sup class="reference" id="cite_ref-116"><a href="#cite_note-116">[116]</a></sup> On December 9, 2015, <i><a href="/wiki/Bloomberg_Businessweek" title="Bloomberg Businessweek">Bloomberg Businessweek</a></i> identified Shkreli as the purchaser.<sup class="reference" id="cite_ref-Leonard2015_102-1"><a href="#cite_note-Leonard2015-102">[102]</a></sup> In February 2016, he announced in an offer letter $10 million to become the sole owner of <a href="/wiki/Kanye_West" title="Kanye West">Kanye West</a>'s album <i><a href="/wiki/The_Life_of_Pablo" title="The Life of Pablo">The Life of Pablo</a></i>.<sup class="reference" id="cite_ref-117"><a href="#cite_note-117">[117]</a></sup><sup class="reference" id="cite_ref-118"><a href="#cite_note-118">[118]</a></sup> On February 12, 2016, Shkreli increased his offer for West's <i>The Life of Pablo</i> from $10 million to $15 million.<sup class="reference" id="cite_ref-119"><a href="#cite_note-119">[119]</a></sup> On August 5, 2016 he became a recurring guest on the Pardon My Take Podcast presented by Barstool Sports.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (August 2016)">citation needed</span></a></i>]</sup> In late October 2016, Shkreli claimed on his Twitter that he would release the album for free download if <a href="/wiki/Donald_Trump" title="Donald Trump">Donald Trump</a> won the <a class="mw-redirect" href="/wiki/2016_US_presidential_election" title="2016 US presidential election">2016 US presidential election</a> and would destroy the album if <a href="/wiki/Hillary_Clinton" title="Hillary Clinton">Hillary Clinton</a> won.<sup class="reference" id="cite_ref-120"><a href="#cite_note-120">[120]</a></sup> He shared the intro and one track the day after <a href="/wiki/Donald_Trump" title="Donald Trump">Donald Trump</a> became the President-elect.<sup class="reference" id="cite_ref-121"><a href="#cite_note-121">[121]</a></sup></p>
<h2><span class="mw-headline" id="Controversies">Controversies</span></h2>
<p>In January 2017, Shkreli's Twitter account was suspended after repeatedly tweeting about dating journalist <a href="/wiki/Lauren_Duca" title="Lauren Duca">Lauren Duca</a>, and then sharing Photoshopped pictures of himself with Duca on his account.<sup class="reference" id="cite_ref-122"><a href="#cite_note-122">[122]</a></sup><sup class="reference" id="cite_ref-123"><a href="#cite_note-123">[123]</a></sup> In another Tweet, Shkreli had promoted "clovergender awareness", referring to a hoax trend of adults identifying as children, while also being <a href="/wiki/Pedophilia" title="Pedophilia">sexually attracted to them</a>.<sup class="reference" id="cite_ref-clover_124-0"><a href="#cite_note-clover-124">[124]</a></sup></p>
<h2><span class="mw-headline" id="References">References</span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-Matthews2015-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Matthews2015_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Matthews2015_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Matthews2015_1-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Matthews, Christopher M.; Copeland, Rob; O'Brien, Rebecca Davis. <a class="external text" href="http://www.wsj.com/articles/martin-shkreli-arrested-on-fraud-charges-1450359637" rel="nofollow">"Martin Shkreli, Pharma Executive, Arrested on Fraud Charges"</a>. <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0099-9660" rel="nofollow">0099-9660</a><span class="reference-accessdate">. Retrieved <span class="nowrap">December 17,</span> 2015</span>. <span style="font-size:90%; color:#555">(subscription required (<span style="border-bottom:1px dotted;cursor:help" title="Sources are not required to be available online. Online sources do not have to be freely available. The site may require a paid subscription.">help</span>))</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli%2C+Pharma+Executive%2C+Arrested+on+Fraud+Charges&amp;rft.au=Copeland%2C+Rob&amp;rft.aufirst=Christopher+M.&amp;rft.aulast=Matthews&amp;rft.au=O%27Brien%2C+Rebecca+Davis&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.wsj.com%2Farticles%2Fmartin-shkreli-arrested-on-fraud-charges-1450359637&amp;rft.issn=0099-9660&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Ortiz2015-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ortiz2015_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ortiz2015_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Ortiz2015_2-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Ortiz, Erik; Dienst, Jonathan; Valiquette, Joe; Hastey, Alicia (December 17, 2015). <a class="external text" href="http://www.nbcnews.com/business/business-news/fbi-arrests-controversial-turing-pharmaceuticals-ceo-martin-shkreli-report-n481671" rel="nofollow">"FBI Arrests Pharma CEO Martin Shkreli on Securities Fraud Charges"</a>. New York: NBC News. <a class="external text" href="https://web.archive.org/web/20160205171323/www.nbcnews.com/business/business-news/fbi-arrests-controversial-turing-pharmaceuticals-ceo-martin-shkreli-report-n481671" rel="nofollow">Archived</a> from the original on February 5, 2016.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.au=Dienst%2C+Jonathan&amp;rft.aufirst=Erik&amp;rft.au=Hastey%2C+Alicia&amp;rft.aulast=Ortiz&amp;rft.au=Valiquette%2C+Joe&amp;rft.btitle=FBI+Arrests+Pharma+CEO+Martin+Shkreli+on+Securities+Fraud+Charges&amp;rft.date=2015-12-17&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.nbcnews.com%2Fbusiness%2Fbusiness-news%2Ffbi-arrests-controversial-turing-pharmaceuticals-ceo-martin-shkreli-report-n481671&amp;rft.place=New+York&amp;rft.pub=NBC+News&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-McLean2015-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-McLean2015_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-McLean2015_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-McLean2015_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-McLean2015_3-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">McLean, Bethany (December 18, 2015). <a class="external text" href="http://www.vanityfair.com/news/2015/12/martin-shkreli-pharmaceuticals-ceo-interview" rel="nofollow">"Everything You Know About Martin Shkreli Is Wrong—or Is It?"</a>. <i>Vanity Fair</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0733-8899" rel="nofollow">0733-8899</a>. <a class="external text" href="https://web.archive.org/web/20160123004738/www.vanityfair.com/news/2015/12/martin-shkreli-pharmaceuticals-ceo-interview" rel="nofollow">Archived</a> from the original on January 23, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">February 7,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Everything+You+Know+About+Martin+Shkreli+Is+Wrong%94or+Is+It%3F&amp;rft.aufirst=Bethany&amp;rft.aulast=McLean&amp;rft.date=2015-12-18&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.vanityfair.com%2Fnews%2F2015%2F12%2Fmartin-shkreli-pharmaceuticals-ceo-interview&amp;rft.issn=0733-8899&amp;rft.jtitle=Vanity+Fair&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Creswell2015a-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-Creswell2015a_4-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Creswell, Julie; Clifford, Stephanie; Pollack, Andrew; Goldstein, Matthew; Chen, David (December 17, 2015). <a class="external text" href="http://www.nytimes.com/2015/12/18/business/shkreli-fraud-charges.html" rel="nofollow">"Drug C.E.O. Martin Shkreli Arrested on Fraud Charges"</a>. <i>The New York Times</i>. pp. A1, B6. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0362-4331" rel="nofollow">0362-4331</a>. <a class="external text" href="https://web.archive.org/web/20160205001624/www.nytimes.com/2015/12/18/business/shkreli-fraud-charges.html" rel="nofollow">Archived</a> from the original on February 5, 2016. <q>Mr. Shkreli, a pharmaceutical industry entrepreneur...</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Drug+C.E.O.+Martin+Shkreli+Arrested+on+Fraud+Charges&amp;rft.au=Chen%2C+David&amp;rft.au=Clifford%2C+Stephanie&amp;rft.aufirst=Julie&amp;rft.au=Goldstein%2C+Matthew&amp;rft.aulast=Creswell&amp;rft.au=Pollack%2C+Andrew&amp;rft.date=2015-12-17&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2015%2F12%2F18%2Fbusiness%2Fshkreli-fraud-charges.html&amp;rft.issn=0362-4331&amp;rft.jtitle=The+New+York+Times&amp;rft.pages=A1%2C-B6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><cite class="citation web">Matyszczyk, Chris (February 4, 2016). <a class="external text" href="http://www.inc.com/chris-matyszczyk/how-martin-shkreli-is-entrepreneurs-best-spokesman.html" rel="nofollow">"Icons of Entrepreneurship: Why Martin Shkreli Speaks For Many Entrepreneurs"</a>. <i>Inc.Com</i>. <a href="/wiki/Inc._(magazine)" title="Inc. (magazine)">Inc. (magazine)</a><span class="reference-accessdate">. Retrieved <span class="nowrap">September 24,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Icons+of+Entrepreneurship%3A+Why+Martin+Shkreli+Speaks+For+Many+Entrepreneurs&amp;rft.aufirst=Chris&amp;rft.aulast=Matyszczyk&amp;rft.date=2016-02-04&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.inc.com%2Fchris-matyszczyk%2Fhow-martin-shkreli-is-entrepreneurs-best-spokesman.html&amp;rft.jtitle=Inc.Com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><cite class="citation web">Rockoff, Jonathan D. (December 17, 2015). <a class="external text" href="http://www.wsj.com/articles/martin-shkreli-from-biotech-entrepreneur-to-accused-criminal-1450389335" rel="nofollow">"Martin Shkreli: From Biotech Entrepreneur to Accused Criminal"</a>. <i>wsj.Com</i>. <a class="mw-redirect" href="/wiki/Wall_Street_Journal" title="Wall Street Journal">Wall Street Journal</a><span class="reference-accessdate">. Retrieved <span class="nowrap">September 24,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli%3A+From+Biotech+Entrepreneur+to+Accused+Criminal&amp;rft.aufirst=Jonathan+D.&amp;rft.aulast=Rockoff&amp;rft.date=2015-12-17&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.wsj.com%2Farticles%2Fmartin-shkreli-from-biotech-entrepreneur-to-accused-criminal-1450389335&amp;rft.jtitle=wsj.Com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><cite class="citation web">Chohan, Usman W. (January 8, 2015). <a class="external text" href="https://theconversation.com/martin-shkreli-and-the-outrage-of-inequality-52812" rel="nofollow">"Martin Shkreli and the outrage of inequality"</a>. The Conversation<span class="reference-accessdate">. Retrieved <span class="nowrap">October 26,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.aufirst=Usman+W.&amp;rft.aulast=Chohan&amp;rft.btitle=Martin+Shkreli+and+the+outrage+of+inequality&amp;rft.date=2015-01-08&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Ftheconversation.com%2Fmartin-shkreli-and-the-outrage-of-inequality-52812&amp;rft.pub=The+Conversation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Thomas2015-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Thomas2015_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Thomas2015_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Thomas2015_8-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Thomas2015_8-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Thomas, Zoe; Swift, Tim (September 23, 2015). <a class="external text" href="http://www.bbc.com/news/world-us-canada-34331761" rel="nofollow">"Who is Martin Shkreli – 'the most hated man in America'?"</a>. London: BBC News. <a class="external text" href="https://web.archive.org/web/20151231023200/www.bbc.com/news/world-us-canada-34331761" rel="nofollow">Archived</a> from the original on December 31, 2015.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.aufirst=Zoe&amp;rft.aulast=Thomas&amp;rft.au=Swift%2C+Tim&amp;rft.btitle=Who+is+Martin+Shkreli+%93+%98the+most+hated+man+in+America%99%3F&amp;rft.date=2015-09-23&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.bbc.com%2Fnews%2Fworld-us-canada-34331761&amp;rft.place=London&amp;rft.pub=BBC+News&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Chung2015-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-Chung2015_9-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Chung, Jen (December 18, 2015). <a class="external text" href="http://gothamist.com/2015/12/18/martin_shkreli_bail_thanks.php" rel="nofollow">"Martin Shkreli Home On $5 Million Bail, Says 'Thanks For The Support<span style="padding-right:0.2em;">'</span>"</a>. <i>Gothamist</i>. <a class="external text" href="http://webcitation.org/query?date=2016-02-06&amp;url=http%3A%2F%2Fgothamist.com%2F2015%2F12%2F18%2Fmartin_shkreli_bail_thanks.php" rel="nofollow">Archived</a> from the original on February 7, 2016.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli+Home+On+%245+Million+Bail%2C+Says+%98Thanks+For+The+Support%99&amp;rft.aufirst=Jen&amp;rft.aulast=Chung&amp;rft.date=2015-12-18&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fgothamist.com%2F2015%2F12%2F18%2Fmartin_shkreli_bail_thanks.php&amp;rft.jtitle=Gothamist&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Shkreli_quits-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-Shkreli_quits_10-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.bbc.com/news/business-35136834" rel="nofollow">"Martin Shkreli quits Turing Pharmaceuticals after arrest"</a>. BBC News. December 18, 2015.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.btitle=Martin+Shkreli+quits+Turing+Pharmaceuticals+after+arrest&amp;rft.date=2015-12-18&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.bbc.com%2Fnews%2Fbusiness-35136834&amp;rft.pub=BBC+News&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><cite class="citation news">Pollack, Andrew (December 19, 2015). <a class="external text" href="http://www.nytimes.com/2015/12/19/business/martin-shkreli-resigns-turing-drug-company.html" rel="nofollow">"Martin Shkreli Resigns From Turing Pharmaceuticals"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli+Resigns+From+Turing+Pharmaceuticals&amp;rft.aufirst=Andrew&amp;rft.aulast=Pollack&amp;rft.date=2015-12-19&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2015%2F12%2F19%2Fbusiness%2Fmartin-shkreli-resigns-turing-drug-company.html&amp;rft.jtitle=The+New+York+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.turingpharma.com/media/press-release?headline=turing-pharmaceuticals-ag-announces-appointment-of-ron-tilles-as-interim-ceo" rel="nofollow">"Turing Pharmaceuticals AG Announces Appointment of Ron Tilles as Interim CEO"</a>. Turing Pharmaceuticals.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.btitle=Turing+Pharmaceuticals+AG+Announces+Appointment+of+Ron+Tilles+as+Interim+CEO&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.turingpharma.com%2Fmedia%2Fpress-release%3Fheadline%3Dturing-pharmaceuticals-ag-announces-appointment-of-ron-tilles-as-interim-ceo&amp;rft.pub=Turing+Pharmaceuticals&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Pearson2015-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-Pearson2015_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Pearson2015_13-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Pearson, Erica (March 9, 2015). <a class="external text" href="http://www.nydailynews.com/new-york/martin-shkreli-thanks-math-teacher-biz-success-article-1.2143505" rel="nofollow">"Hunter College High School gets record $1M gift from grad"</a>. <i><a class="mw-redirect" href="/wiki/Daily_News_(New_York)" title="Daily News (New York)">Daily News</a></i>. New York. <a class="external text" href="https://web.archive.org/web/20160124202249/www.nydailynews.com/new-york/martin-shkreli-thanks-math-teacher-biz-success-article-1.2143505" rel="nofollow">Archived</a> from the original on January 24, 2016.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Hunter+College+High+School+gets+record+%241M+gift+from+grad&amp;rft.aufirst=Erica&amp;rft.aulast=Pearson&amp;rft.date=2015-03-09&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.nydailynews.com%2Fnew-york%2Fmartin-shkreli-thanks-math-teacher-biz-success-article-1.2143505&amp;rft.jtitle=Daily+News&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Gould2015-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-Gould2015_14-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Gould, Martin; McLaughlin, Kelly (September 28, 2015) [1st pub. September 22, 2015]. <a class="external text" href="http://www.dailymail.co.uk/news/article-3245759/Martin-Skli-stalked-former-employee-wife-vowed-make-homeless-campaign-harassment.html" rel="nofollow">"Retrophin CEO Martin Shkreli 'stalked' former employee and his wife"</a>. <i>Daily Mail</i>. London. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0307-7578" rel="nofollow">0307-7578</a>. <a class="external text" href="https://web.archive.org/web/20160202102300id_/www.dailymail.co.uk/news/article-3245759/Martin-Skli-stalked-former-employee-wife-vowed-make-homeless-campaign-harassment.html#js-article-text" rel="nofollow">Archived</a> from the original on February 2, 2016.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Retrophin+CEO+Martin+Shkreli+%98stalked%99+former+employee+and+his+wife&amp;rft.aufirst=Martin&amp;rft.aulast=Gould&amp;rft.au=McLaughlin%2C+Kelly&amp;rft.date=2015-09-28&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.dailymail.co.uk%2Fnews%2Farticle-3245759%2FMartin-Skli-stalked-former-employee-wife-vowed-make-homeless-campaign-harassment.html&amp;rft.issn=0307-7578&amp;rft.jtitle=Daily+Mail&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Creswell2015-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-Creswell2015_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Creswell2015_15-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Creswell, Julie; Clifford, Stephanie; Pollack, Andrew; Goldstein, Matthew; Chen, David (December 17, 2015). <a class="external text" href="http://www.nytimes.com/2015/12/18/business/shkreli-fraud-charges.html" rel="nofollow">"Drug C.E.O. Martin Shkreli Arrested on Fraud Charges"</a>. <i>The New York Times</i>. pp. A1, B6. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0362-4331" rel="nofollow">0362-4331</a>. <a class="external text" href="https://web.archive.org/web/20160205001624/www.nytimes.com/2015/12/18/business/shkreli-fraud-charges.html" rel="nofollow">Archived</a> from the original on February 5, 2016.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Drug+C.E.O.+Martin+Shkreli+Arrested+on+Fraud+Charges&amp;rft.au=Chen%2C+David&amp;rft.au=Clifford%2C+Stephanie&amp;rft.aufirst=Julie&amp;rft.au=Goldstein%2C+Matthew&amp;rft.aulast=Creswell&amp;rft.au=Pollack%2C+Andrew&amp;rft.date=2015-12-17&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2015%2F12%2F18%2Fbusiness%2Fshkreli-fraud-charges.html&amp;rft.issn=0362-4331&amp;rft.jtitle=The+New+York+Times&amp;rft.pages=A1%2C-B6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><a class="external free" href="https://www.youtube.com/watch?v=HWd4-Z0xBos" rel="nofollow">https://www.youtube.com/watch?v=HWd4-Z0xBos</a></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://www.youtube.com/watch?v=JTNOWSKMS10" rel="nofollow">"Martin Shkreli Interview at The Breakfast Club Power 105.1 (02/03/2016)"</a>. YouTube<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-02-07</span></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.btitle=Martin+Shkreli+Interview+at+The+Breakfast+Club+Power+105.1+%2802%2F03%2F2016%29&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DJTNOWSKMS10&amp;rft.pub=YouTube&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Pollack2015a-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-Pollack2015a_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Pollack2015a_18-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Pollack2015a_18-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Pollack2015a_18-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Pollack2015a_18-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Pollack, Andrew; Creswell, Julie (September 22, 2015). <a class="external text" href="http://www.nytimes.com/2015/09/23/business/big-price-increase-for-an-old-drug-will-be-rolled-back-turing-chief-says.html" rel="nofollow">"Martin Shkreli, the Mercurial Man Behind the Drug Price Increase That Went Viral"</a>. <i>The New York Times</i>. p. B1. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0362-4331" rel="nofollow">0362-4331</a>. <a class="external text" href="https://web.archive.org/web/20151206233054/www.nytimes.com/2015/09/23/business/big-price-increase-for-an-old-drug-will-be-rolled-back-turing-chief-says.html" rel="nofollow">Archived</a> from the original on December 6, 2015.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli%2C+the+Mercurial+Man+Behind+the+Drug+Price+Increase+That+Went+Viral&amp;rft.au=Creswell%2C+Julie&amp;rft.aufirst=Andrew&amp;rft.aulast=Pollack&amp;rft.date=2015-09-22&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2015%2F09%2F23%2Fbusiness%2Fbig-price-increase-for-an-old-drug-will-be-rolled-back-turing-chief-says.html&amp;rft.issn=0362-4331&amp;rft.jtitle=The+New+York+Times&amp;rft.pages=B1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Chen2015-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-Chen2015_19-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Chen, David W.; Rosenberg, Eli (December 24, 2015) [1st pub. December 18, 2015]. <a class="external text" href="http://www.nytimes.com/2015/12/19/nyregion/a-surprise-gift-from-martin-shkreli-who-became-a-hated-ceo.html" rel="nofollow">"Martin Shkreli's Arrest Fuels Debate Over $1 Million Donation"</a>. <i>The New York Times</i>. p. A17. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0362-4331" rel="nofollow">0362-4331</a>. <a class="external text" href="https://web.archive.org/web/20151231155406/www.nytimes.com/2015/12/19/nyregion/a-surprise-gift-from-martin-shkreli-who-became-a-hated-ceo.html" rel="nofollow">Archived</a> from the original on December 31, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">February 7,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli%99s+Arrest+Fuels+Debate+Over+%241+Million+Donation&amp;rft.aufirst=David+W.&amp;rft.aulast=Chen&amp;rft.au=Rosenberg%2C+Eli&amp;rft.date=2015-12-24&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2015%2F12%2F19%2Fnyregion%2Fa-surprise-gift-from-martin-shkreli-who-became-a-hated-ceo.html&amp;rft.issn=0362-4331&amp;rft.jtitle=The+New+York+Times&amp;rft.pages=A17&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="http://www.newsweek.com/homeless-charity-says-it-will-give-shkrelis-15000-back-407220" rel="nofollow">"Homeless Charity Says It Will Give Shkreli's $15,000 Back"</a>. <i>Newsweek</i>. Reuters. December 18, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">December 19,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Homeless+Charity+Says+It+Will+Give+Shkreli%99s+%2415%2C000+Back&amp;rft.date=2015-12-18&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.newsweek.com%2Fhomeless-charity-says-it-will-give-shkrelis-15000-back-407220&amp;rft.jtitle=Newsweek&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Barrett2014-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-Barrett2014_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Barrett2014_21-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Barrett2014_21-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Barrett2014_21-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Barrett2014_21-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Barrett, Paul (April 17, 2014). <a class="external text" href="http://www.bloomberg.com/bw/articles/2014-04-17/retrophins-martin-shkreli-the-biotech-short-seller-who-went-long" rel="nofollow">"Retrophin's Martin Shkreli, the Biotech Short Seller Who Went Long"</a>. <i><a href="/wiki/Bloomberg_Businessweek" title="Bloomberg Businessweek">Bloomberg Businessweek</a></i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0007-7135" rel="nofollow">0007-7135</a><span class="reference-accessdate">. Retrieved <span class="nowrap">December 17,</span> 2015</span>. <q>Once a Notorious Short Seller, Martin Shkreli Now Sees a Future in Biotech</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Retrophin%27s+Martin+Shkreli%2C+the+Biotech+Short+Seller+Who+Went+Long&amp;rft.aufirst=Paul&amp;rft.aulast=Barrett&amp;rft.date=2014-04-17&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fbw%2Farticles%2F2014-04-17%2Fretrophins-martin-shkreli-the-biotech-short-seller-who-went-long&amp;rft.issn=0007-7135&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><a class="external text" href="http://www.thestreet.com/author/1101137/MartinShkreli/all.html" rel="nofollow">"Martin Shkreli"</a>. TheStreet.com. Retrieved December 17, 2015.</span></li>
<li id="cite_note-nytindictment-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-nytindictment_23-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="http://www.nytimes.com/2015/12/18/business/dealbook/shkreli-indictment-portrays-small-time-fraud.html" rel="nofollow">"Shkreli Indictment Portrays Small-Time Fraud"</a>. <i>The New York Times</i>. December 18, 2015.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Shkreli+Indictment+Portrays+Small-Time+Fraud&amp;rft.date=2015-12-18&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2015%2F12%2F18%2Fbusiness%2Fdealbook%2Fshkreli-indictment-portrays-small-time-fraud.html&amp;rft.jtitle=The+New+York+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text">La Roche, Julia; Jacobs, Peter (December 17, 2015). <a class="external text" href="http://www.businessinsider.com/martin-shkreli-arrested-in-securities-fraud-investigation-2015-12" rel="nofollow">"Hedge funder Martin Shkreli has been arrested in a securities-fraud investigation"</a>, <i><a href="/wiki/Business_Insider" title="Business Insider">Business Insider</a></i>, December 2015.</span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><cite class="citation news">Pollack, Andrew (February 1, 2011). <a class="external text" href="http://www.nytimes.com/2011/02/02/business/02drug.html" rel="nofollow">"FDA Declines to Approve Diet Drug"</a>. <i>The New York Times</i>. <q>Shares of Orexigen plunged 72.5 percent on Tuesday, to $2.50</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=FDA+Declines+to+Approve+Diet+Drug&amp;rft.aufirst=Andrew&amp;rft.aulast=Pollack&amp;rft.date=2011-02-01&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2011%2F02%2F02%2Fbusiness%2F02drug.html&amp;rft.jtitle=The+New+York+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-FBI2015-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-FBI2015_26-0">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a class="external text" href="https://www.fbi.gov/newyork/press-releases/2015/former-hedge-fund-manager-and-new-york-attorney-indicted-in-multi-million-dollar-fraud-scheme" rel="nofollow">"Former Hedge Fund Manager and New York Attorney Indicted in Multi‑Million‑Dollar Fraud Scheme"</a> (Press release). Federal Bureau of Investigation. December 17, 2015. <a class="external text" href="https://web.archive.org/web/20151231040349/www.fbi.gov/newyork/press-releases/2015/former-hedge-fund-manager-and-new-york-attorney-indicted-in-multi-million-dollar-fraud-scheme" rel="nofollow">Archived</a> from the original on December 31, 2015. <q>In February 2011, MSMB Capital failed to settle a short position of more than 11 million shares of Orexigen Therapeutics ... that Merrill Lynch ultimately closed at a loss of over $7 million</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.btitle=Former+Hedge+Fund+Manager+and+New+York+Attorney+Indicted+in+Multi%91Million%91Dollar+Fraud+Scheme&amp;rft.date=2015-12-17&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fwww.fbi.gov%2Fnewyork%2Fpress-releases%2F2015%2Fformer-hedge-fund-manager-and-new-york-attorney-indicted-in-multi-million-dollar-fraud-scheme&amp;rft.pub=Federal+Bureau+of+Investigation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><cite class="citation web">Hiltzik, Michael (December 17, 2015). <a class="external text" href="http://www.latimes.com/business/hiltzik/la-fi-mh-martin-shkreli-was-one-terrible-investor-20151217-column.html" rel="nofollow">"Martin Shkreli was one terrible investor, SEC document shows"</a>. <i>latimes.com</i>. <i><a href="/wiki/Los_Angeles_Times" title="Los Angeles Times">Los Angeles Times</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">August 8,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli+was+one+terrible+investor%2C+SEC+document+shows&amp;rft.aufirst=Michael&amp;rft.aulast=Hiltzik&amp;rft.date=2015-12-17&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.latimes.com%2Fbusiness%2Fhiltzik%2Fla-fi-mh-martin-shkreli-was-one-terrible-investor-20151217-column.html&amp;rft.jtitle=latimes.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-SEC_Court_Filing-28"><span class="mw-cite-backlink">^ <a href="#cite_ref-SEC_Court_Filing_28-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-SEC_Court_Filing_28-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-SEC_Court_Filing_28-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a href="/wiki/United_States_District_Court_for_the_Southern_District_of_New_York" title="United States District Court for the Southern District of New York">United States District Court for the Southern District of New York</a> (October 17, 2015). <a class="external text" href="http://www.sec.gov/Archives/edgar/data/1438533/000119312515292581/d19898dex991.htm" rel="nofollow">"EX-99.1, Retrophin, Inc. v. Martin Shkreli"</a>. <i>SEC.gov (<a href="/wiki/EDGAR" title="EDGAR">EDGAR</a>)</i>. <a href="/wiki/U.S._Securities_and_Exchange_Commission" title="U.S. Securities and Exchange Commission">United States Securities and Exchange Commission</a><span class="reference-accessdate">. Retrieved <span class="nowrap">September 22,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=EX-99.1%2C+Retrophin%2C+Inc.+v.+Martin+Shkreli&amp;rft.au=United+States+District+Court+for+the+Southern+District+of+New+York&amp;rft.date=2015-10-17&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F1438533%2F000119312515292581%2Fd19898dex991.htm&amp;rft.jtitle=SEC.gov+%28EDGAR%29&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><cite class="citation web">Silverman, Ed (September 26, 2015). <a class="external text" href="https://www.bostonglobe.com/business/2015/09/25/how-martin-shkreli-biotech-pariah-put-cancer-patients-risk/fxjUV8alj28LESmmOF7IbO/story.html" rel="nofollow">"Biotech Exec Martin Shkreli Has History of Tough Tactics"</a>. <i><a href="/wiki/The_Boston_Globe" title="The Boston Globe">The Boston Globe</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">September 28,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Biotech+Exec+Martin+Shkreli+Has+History+of+Tough+Tactics&amp;rft.aufirst=Ed&amp;rft.aulast=Silverman&amp;rft.date=2015-09-26&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2015%2F09%2F25%2Fhow-martin-shkreli-biotech-pariah-put-cancer-patients-risk%2FfxjUV8alj28LESmmOF7IbO%2Fstory.html&amp;rft.jtitle=The+Boston+Globe&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.finalternatives.com/node/21072" rel="nofollow">"Hedge Fund Manager Denies CREW Allegations"</a>. <i>FINalternatives</i>. July 17, 2012.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Hedge+Fund+Manager+Denies+CREW+Allegations&amp;rft.date=2012-07-17&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.finalternatives.com%2Fnode%2F21072&amp;rft.jtitle=FINalternatives&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><cite class="citation web">Nussbaum, Alex (October 3, 2011). <a class="external text" href="http://www.bloomberg.com/news/2011-08-03/msmb-capital-offers-378-million-to-take-over-anemia-drug-maker-amag.html" rel="nofollow">"MSMB Capital Makes Unsolicited $378M Bid For AMAG Pharmaceuticals"</a>. <i><a href="/wiki/Bloomberg_Businessweek" title="Bloomberg Businessweek">Bloomberg Businessweek</a></i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0007-7135" rel="nofollow">0007-7135</a><span class="reference-accessdate">. Retrieved <span class="nowrap">December 9,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=MSMB+Capital+Makes+Unsolicited+%24378M+Bid+For+AMAG+Pharmaceuticals&amp;rft.aufirst=Alex&amp;rft.aulast=Nussbaum&amp;rft.date=2011-10-03&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2011-08-03%2Fmsmb-capital-offers-378-million-to-take-over-anemia-drug-maker-amag.html&amp;rft.issn=0007-7135&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><cite class="citation web">Herper, Matthew (December 18, 2012). <a class="external text" href="http://www.forbes.com/sites/matthewherper/2012/12/18/30-under-30-hedge-fund-gadfly-turns-biotech-entrepreneur/#260b9c6376de" rel="nofollow">"30 Under 30: Hedge Fund Gadfly Turns Biotech Entrepreneur"</a>. <i>forbes.com</i>. <a href="/wiki/Forbes" title="Forbes">Forbes</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 8,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=30+Under+30%3A+Hedge+Fund+Gadfly+Turns+Biotech+Entrepreneur&amp;rft.aufirst=Matthew&amp;rft.aulast=Herper&amp;rft.date=2012-12-18&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F12%2F18%2F30-under-30-hedge-fund-gadfly-turns-biotech-entrepreneur%2F%23260b9c6376de&amp;rft.jtitle=forbes.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text">Silverman, Ed (December 17, 2015). <a class="external text" href="http://www.statnews.com/2015/12/17/17920/" rel="nofollow">"Reviled CEO Martin Shkreli arrested on securities fraud charges"</a>. STAT. <a class="mw-redirect" href="/wiki/Boston_Globe_Media_Partners" title="Boston Globe Media Partners">Boston Globe Media Partners</a>.</span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text">Weintrub, Arlene (August 18, 2015). <a class="external text" href="http://www.forbes.com/sites/arleneweintraub/2015/08/18/retrophin-sues-founder-martin-shkreli-for-65m-his-reply-preposterous/" rel="nofollow">"Retrophin Sues Founder Martin Shkreli For $65M. His Reply: 'Preposterous'"</a>, <i>Forbes</i>. Retrieved December 23, 2015.</span></li>
<li id="cite_note-Retrophin-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-Retrophin_35-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://web.archive.org/web/20111230124848/www.retrophin.com/aboutus.html" rel="nofollow">"Retrophin: About Us"</a>. Archived from <a class="external text" href="http://www.retrophin.com/aboutus.html" rel="nofollow">the original</a> on December 30, 2011.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.btitle=Retrophin%3A+About+Us&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.retrophin.com%2Faboutus.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.bloomberg.com/research/stocks/people/person.asp?personId=207372&amp;ticker=BMRN" rel="nofollow">"Stephen J. Aselage biography"</a>. Bloomberg. September 22, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">September 22,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.btitle=Stephen+J.+Aselage+biography&amp;rft.date=2015-09-22&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fresearch%2Fstocks%2Fpeople%2Fperson.asp%3FpersonId%3D207372%26ticker%3DBMRN&amp;rft.pub=Bloomberg&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><cite class="citation web">Feuerstein, Adam. <a class="external text" href="http://www.thestreet.com/story/12839330/1/retrophin-ceo-under-fire-for-twitter-faux-pas.html" rel="nofollow">"Retrophin CEO Under Fire for Twitter Faux Pas"</a>. <i>TheStreet</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Retrophin+CEO+Under+Fire+for+Twitter+Faux+Pas&amp;rft.aufirst=Adam&amp;rft.aulast=Feuerstein&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.thestreet.com%2Fstory%2F12839330%2F1%2Fretrophin-ceo-under-fire-for-twitter-faux-pas.html&amp;rft.jtitle=TheStreet&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><cite class="citation web">Feuerstein, Adam. <a class="external text" href="http://www.thestreet.com/story/12897910/1/shkrelis-inability-to-focus-immaturity-cost-him-retrophin-ceo-job.html" rel="nofollow">"Shkreli's Inability to Focus, Immaturity Cost Him Retrophin CEO Job"</a>. <i>TheStreet</i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 23,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Shkreli%27s+Inability+to+Focus%2C+Immaturity+Cost+Him+Retrophin+CEO+Job&amp;rft.aufirst=Adam&amp;rft.aulast=Feuerstein&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.thestreet.com%2Fstory%2F12897910%2F1%2Fshkrelis-inability-to-focus-immaturity-cost-him-retrophin-ceo-job.html&amp;rft.jtitle=TheStreet&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><cite class="citation web">Milford, Phil; Tracer, Zachary (August 17, 2015). <a class="external text" href="http://www.bloomberg.com/news/articles/2015-08-17/retrophin-sues-founder-shkreli-for-65-million-in-u-s-court" rel="nofollow">"Retrophin Sues Founder in Latest Fight Over Use of Funds"</a>. <i><a href="/wiki/Bloomberg_Businessweek" title="Bloomberg Businessweek">Bloomberg Businessweek</a></i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0007-7135" rel="nofollow">0007-7135</a><span class="reference-accessdate">. Retrieved <span class="nowrap">September 22,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Retrophin+Sues+Founder+in+Latest+Fight+Over+Use+of+Funds&amp;rft.aufirst=Phil&amp;rft.aulast=Milford&amp;rft.au=Tracer%2C+Zachary&amp;rft.date=2015-08-17&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2015-08-17%2Fretrophin-sues-founder-shkreli-for-65-million-in-u-s-court&amp;rft.issn=0007-7135&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><cite class="citation web">Weintraub, Arlene (October 15, 2015). <a class="external text" href="http://www.forbes.com/sites/arleneweintraub/2015/08/18/retrophin-sues-founder-martin-shkreli-for-65m-his-reply-preposterous" rel="nofollow">"Retrophin Sues Founder Martin Shkreli For $65M. His Reply: 'Preposterous<span style="padding-right:0.2em;">'</span>"</a>. <i>Forbes</i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Retrophin+Sues+Founder+Martin+Shkreli+For+%2465M.+His+Reply%3A+%27Preposterous%27&amp;rft.aufirst=Arlene&amp;rft.aulast=Weintraub&amp;rft.date=2015-10-15&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.forbes.com%2Fsites%2Farleneweintraub%2F2015%2F08%2F18%2Fretrophin-sues-founder-martin-shkreli-for-65m-his-reply-preposterous&amp;rft.jtitle=Forbes&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><cite class="citation web">Barrett, Paul (October 2, 2014). <a class="external text" href="http://www.bloomberg.com/bw/articles/2014-10-02/biotech-company-retrophin-fired-ceo-because-of-stock-irregularities" rel="nofollow">"Executives: Biotech Company Retrophin Fired CEO Because of Stock Irregularities"</a>. <i>Bloomberg Businessweek</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0007-7135" rel="nofollow">0007-7135</a><span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Executives%3A+Biotech+Company+Retrophin+Fired+CEO+Because+of+Stock+Irregularities&amp;rft.aufirst=Paul&amp;rft.aulast=Barrett&amp;rft.date=2014-10-02&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fbw%2Farticles%2F2014-10-02%2Fbiotech-company-retrophin-fired-ceo-because-of-stock-irregularities&amp;rft.issn=0007-7135&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><cite class="citation web">Mangan, Dan (September 22, 2015). <a class="external text" href="http://www.cnbc.com/2015/09/22/controversial-drug-ceo-was-accused-of-serious-harassment.html" rel="nofollow">"Controversial Drug CEO was Accused of Serious 'Harassment<span style="padding-right:0.2em;">'</span>"</a>. CNBC<span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.aufirst=Dan&amp;rft.aulast=Mangan&amp;rft.btitle=Controversial+Drug+CEO+was+Accused+of+Serious+%27Harassment%27&amp;rft.date=2015-09-22&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.cnbc.com%2F2015%2F09%2F22%2Fcontroversial-drug-ceo-was-accused-of-serious-harassment.html&amp;rft.pub=CNBC&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-NW20150927-43"><span class="mw-cite-backlink">^ <a href="#cite_ref-NW20150927_43-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NW20150927_43-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Eichenwald, Kurt (September 23, 2015). <a class="external text" href="http://www.newsweek.com/martin-shkreli-drug-manipulation-daraprim-retrophin-375416" rel="nofollow">"Federal Prosecutors Target Martin Shkreli in a Criminal Investigation"</a>. <i>Newsweek</i><span class="reference-accessdate">. Retrieved <span class="nowrap">September 27,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Federal+Prosecutors+Target+Martin+Shkreli+in+a+Criminal+Investigation&amp;rft.aufirst=Kurt&amp;rft.aulast=Eichenwald&amp;rft.date=2015-09-23&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.newsweek.com%2Fmartin-shkreli-drug-manipulation-daraprim-retrophin-375416&amp;rft.jtitle=Newsweek&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><cite class="citation web">Barrett, Paul (February 23, 2015). <a class="external text" href="http://www.bloomberg.com/news/articles/2015-02-23/biotech-s-boy-genius-faces-new-allegations-of-wrongdoing" rel="nofollow">"Biotech's 'Boy Genius' Faces New Allegations of Wrongdoing"</a>. <i>Bloomberg Businessweek</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0007-7135" rel="nofollow">0007-7135</a><span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>. <q>Subtitle: Retrophin fired former CEO Martin Shkreli in October, and their new SEC filing reveals more about his apparent misdeeds.</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Biotech%27s+%27Boy+Genius%27+Faces+New+Allegations+of+Wrongdoing&amp;rft.aufirst=Paul&amp;rft.aulast=Barrett&amp;rft.date=2015-02-23&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2015-02-23%2Fbiotech-s-boy-genius-faces-new-allegations-of-wrongdoing&amp;rft.issn=0007-7135&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><span class="citation patent"><a class="external text" href="https://worldwide.espacenet.com/textdoc?DB=EPODOC&amp;IDX=US8673883" rel="nofollow">US patent 8673883</a>, "Pantothenate derivatives for the treatment of neurologic disorders"</span><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&amp;rft.number=8673883&amp;rft.cc=US&amp;rft.title=Pantothenate+derivatives+for+the+treatment+of+neurologic+disorders"><span style="display: none;"> </span></span> <span class="citation patent"><a class="external text" href="https://worldwide.espacenet.com/textdoc?DB=EPODOC&amp;IDX=US9181286" rel="nofollow">US patent 9181286</a>, "Pantothenate derivatives for the treatment of neurologic disorders"</span><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&amp;rft.number=9181286&amp;rft.cc=US&amp;rft.title=Pantothenate+derivatives+for+the+treatment+of+neurologic+disorders"><span style="display: none;"> </span></span><cite class="citation web"><a class="external text" href="https://www.google.com/patents/WO2013163576A1" rel="nofollow">"Google patents"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">December 23,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.btitle=Google+patents&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fwww.google.com%2Fpatents%2FWO2013163576A1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Allen2015-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-Allen2015_46-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Allen, Samantha (September 21, 2015). <a class="external text" href="http://www.thedailybeast.com/articles/2015/09/21/martin-shkreli-is-big-pharma-s-biggest-asshole.html" rel="nofollow">"Martin Shkreli Is Big Pharma's Biggest A**hole"</a>. <i>The Daily Beast</i>. <a class="external text" href="http://timetravel.mementoweb.org/memento/20150922100057/www.thedailybeast.com/articles/2015/09/21/martin-shkreli-is-big-pharma-s-biggest-asshole.html" rel="nofollow">Archived</a> from the original on September 22, 2015.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli+Is+Big+Pharma%99s+Biggest+A%2A%2Ahole&amp;rft.aufirst=Samantha&amp;rft.aulast=Allen&amp;rft.date=2015-09-21&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.thedailybeast.com%2Farticles%2F2015%2F09%2F21%2Fmartin-shkreli-is-big-pharma-s-biggest-asshole.html&amp;rft.jtitle=The+Daily+Beast&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-imprimis-47"><span class="mw-cite-backlink">^ <a href="#cite_ref-imprimis_47-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-imprimis_47-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Sternberg, Steve (February 10, 2016). <a class="external text" href="http://www.usnews.com/news/articles/2016-02-10/drugmaker-imprimis-to-market-a-cheaper-kidney-stone-treatment" rel="nofollow">"Drugmaker Imprimis to Market a Cheaper Kidney Stone Treatment"</a>. <i>usnews.com</i>. <i><a href="/wiki/U.S._News_%26_World_Report" title="U.S. News &amp; World Report">U.S. News &amp; World Report</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">August 8,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Drugmaker+Imprimis+to+Market+a+Cheaper+Kidney+Stone+Treatment&amp;rft.aufirst=Steve&amp;rft.aulast=Sternberg&amp;rft.date=2016-02-10&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.usnews.com%2Fnews%2Farticles%2F2016-02-10%2Fdrugmaker-imprimis-to-market-a-cheaper-kidney-stone-treatment&amp;rft.jtitle=usnews.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><cite class="citation web"><a href="/wiki/Derek_Lowe_(chemist)" title="Derek Lowe (chemist)">Lowe, Derek</a> (September 11, 2014). <a class="external text" href="http://blogs.sciencemag.org/pipeline/archives/2014/09/11/the_most_unconscionable_drug_price_hike_i_have_yet_seen" rel="nofollow">"The Most Unconscionable Drug Price Hike I Have Yet Seen"</a>. <i>sciencemag.org</i>. <a href="/wiki/American_Association_for_the_Advancement_of_Science" title="American Association for the Advancement of Science">American Association for the Advancement of Science</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 8,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=The+Most+Unconscionable+Drug+Price+Hike+I+Have+Yet+Seen&amp;rft.aufirst=Derek&amp;rft.aulast=Lowe&amp;rft.date=2014-09-11&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fblogs.sciencemag.org%2Fpipeline%2Farchives%2F2014%2F09%2F11%2Fthe_most_unconscionable_drug_price_hike_i_have_yet_seen&amp;rft.jtitle=sciencemag.org&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://fortune.com/2015/12/18/major-pharmacies-martin-shkreli/" rel="nofollow">"How Pharmacies Are Dealing with Daraprim After Martin Shkreli's Arrest"</a>. <i>fortune.com</i>. <i><a href="/wiki/Fortune_(magazine)" title="Fortune (magazine)">Fortune</a></i>. December 18, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">August 8,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=How+Pharmacies+Are+Dealing+with+Daraprim+After+Martin+Shkreli%27s+Arrest&amp;rft.date=2015-12-18&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Ffortune.com%2F2015%2F12%2F18%2Fmajor-pharmacies-martin-shkreli%2F&amp;rft.jtitle=fortune.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.prnewswire.com/news-releases/imprimis-pharmaceuticals-begins-dispensing-lower-cost-alternative-to-thiola-300260518.html" rel="nofollow">"Imprimis Pharmaceuticals Begins Dispensing Lower Cost Alternative to Thiola®"</a>. <i>prnewswire.com</i>. <a href="/wiki/PR_Newswire" title="PR Newswire">PR Newswire</a>. May 2, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">August 8,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Imprimis+Pharmaceuticals+Begins+Dispensing+Lower+Cost+Alternative+to+Thiola%AE&amp;rft.date=2016-05-02&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fimprimis-pharmaceuticals-begins-dispensing-lower-cost-alternative-to-thiola-300260518.html&amp;rft.jtitle=prnewswire.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><cite class="citation web">Weintraub, Arlene (February 27, 2015). <a class="external text" href="http://www.forbes.com/sites/arleneweintraub/2015/02/27/gadfly-pharma-investor-shkreli-starts-anew-after-ousting-from-retrophin/" rel="nofollow">"Gadfly Pharma Investor Shkreli Starts Anew After Ousting From Retrophin"</a>. <i>Forbes</i><span class="reference-accessdate">. Retrieved <span class="nowrap">September 24,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Gadfly+Pharma+Investor+Shkreli+Starts+Anew+After+Ousting+From+Retrophin&amp;rft.aufirst=Arlene&amp;rft.aulast=Weintraub&amp;rft.date=2015-02-27&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.forbes.com%2Fsites%2Farleneweintraub%2F2015%2F02%2F27%2Fgadfly-pharma-investor-shkreli-starts-anew-after-ousting-from-retrophin%2F&amp;rft.jtitle=Forbes&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Surowiecki151012-52"><span class="mw-cite-backlink">^ <a href="#cite_ref-Surowiecki151012_52-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Surowiecki151012_52-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Surowiecki151012_52-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a href="/wiki/James_Surowiecki" title="James Surowiecki">Surowiecki, James</a> (October 12, 2015). <a class="external text" href="http://www.newyorker.com/magazine/2015/10/12/taking-on-the-drug-profiteers" rel="nofollow">"The Financial Page: Taking on the Drug Profiteers"</a>. <i><a href="/wiki/The_New_Yorker" title="The New Yorker">The New Yorker</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=The+Financial+Page%3A+Taking+on+the+Drug+Profiteers&amp;rft.aufirst=James&amp;rft.aulast=Surowiecki&amp;rft.date=2015-10-12&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.newyorker.com%2Fmagazine%2F2015%2F10%2F12%2Ftaking-on-the-drug-profiteers&amp;rft.jtitle=The+New+Yorker&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Lowe2015-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lowe2015_53-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Lowe, Derek (September 21, 2015). <a class="external text" href="http://blogs.sciencemag.org/pipeline/archives/2015/09/21/martin-shkreli-has-one-idea-and-its-a-bad-one" rel="nofollow">"Blog: Martin Shkreli Has One Idea, And It's a Bad One"</a>. <i>In the Pipeline</i>. <a href="/wiki/OCLC" title="OCLC">OCLC</a> <a class="external text" href="//www.worldcat.org/oclc/5942328021" rel="nofollow">5942328021</a><span class="reference-accessdate">. Retrieved <span class="nowrap">December 9,</span> 2015</span> – via Science Translational Medicine.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Blog%3A+Martin+Shkreli+Has+One+Idea%2C+And+It%99s+a+Bad+One&amp;rft.aufirst=Derek&amp;rft.aulast=Lowe&amp;rft.date=2015-09-21&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fblogs.sciencemag.org%2Fpipeline%2Farchives%2F2015%2F09%2F21%2Fmartin-shkreli-has-one-idea-and-its-a-bad-one&amp;rft_id=info%3Aoclcnum%2F5942328021&amp;rft.jtitle=In+the+Pipeline&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><cite class="citation web">Norviel, Vern; Hoffmeister, David M. (September 30, 2015). <a class="external text" href="http://www.law360.com/articles/709116/a-look-at-the-legality-behind-daraprim-s-price-spike" rel="nofollow">"A Look At The Legality Behind Daraprim's Price Spike"</a>. <i>law360.com</i>. <a href="/wiki/Law360" title="Law360">Law360</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 8,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=A+Look+At+The+Legality+Behind+Daraprim%27s+Price+Spike&amp;rft.aufirst=Vern&amp;rft.au=Hoffmeister%2C+David+M.&amp;rft.aulast=Norviel&amp;rft.date=2015-09-30&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.law360.com%2Farticles%2F709116%2Fa-look-at-the-legality-behind-daraprim-s-price-spike&amp;rft.jtitle=law360.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-NBCSpark-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-NBCSpark_55-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Mitchell, Andrea; Helsel, Phil (September 23, 2015). <a class="external text" href="http://www.nbcnews.com/news/us-news/drug-ceo-will-lower-price-daraprim-after-outrage-n431926" rel="nofollow">"Drug CEO Will Lower Price of Daraprim After Hike Sparked Outrage"</a>. NBC News<span class="reference-accessdate">. Retrieved <span class="nowrap">September 23,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.aufirst=Andrea&amp;rft.au=Helsel%2C+Phil&amp;rft.aulast=Mitchell&amp;rft.btitle=Drug+CEO+Will+Lower+Price+of+Daraprim+After+Hike+Sparked+Outrage&amp;rft.date=2015-09-23&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.nbcnews.com%2Fnews%2Fus-news%2Fdrug-ceo-will-lower-price-daraprim-after-outrage-n431926&amp;rft.pub=NBC+News&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><cite class="citation web">Woods, James. <a class="external text" href="http://usuncut.com/news/company-hikes-price-5000-for-life-saving-cancer-and-aids-drug" rel="nofollow">"Company Hikes Price 5,000% For Life-Saving Cancer and AIDS Drug"</a>. <i>U.S. Uncut</i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 23,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Company+Hikes+Price+5%2C000%25+For+Life-Saving+Cancer+and+AIDS+Drug&amp;rft.aufirst=James&amp;rft.aulast=Woods&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fusuncut.com%2Fnews%2Fcompany-hikes-price-5000-for-life-saving-cancer-and-aids-drug&amp;rft.jtitle=U.S.+Uncut&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-TimmermanForbes150923-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-TimmermanForbes150923_57-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Timmerman, Luke (September 23, 2015). <a class="external text" href="http://www.forbes.com/sites/luketimmerman/2015/09/23/a-timeline-of-the-turing-pharma-controversy" rel="nofollow">"Pharma &amp; Healthcare: A Timeline of the Turing Pharma Controversy"</a>. <i>Forbes</i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Pharma+%26+Healthcare%3A+A+Timeline+of+the+Turing+Pharma+Controversy&amp;rft.aufirst=Luke&amp;rft.aulast=Timmerman&amp;rft.date=2015-09-23&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fluketimmerman%2F2015%2F09%2F23%2Fa-timeline-of-the-turing-pharma-controversy&amp;rft.jtitle=Forbes&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-NYTOvernight-58"><span class="mw-cite-backlink">^ <a href="#cite_ref-NYTOvernight_58-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NYTOvernight_58-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NYTOvernight_58-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Pollack, Andrew (September 20, 2015). <a class="external text" href="http://www.nytimes.com/2015/09/21/business/a-huge-overnight-increase-in-a-drugs-price-raises-protests.html" rel="nofollow">"Business Day: Drug Goes From $13.50 a Tablet to $750, Overnight"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Business+Day%3A+Drug+Goes+From+%2413.50+a+Tablet+to+%24750%2C+Overnight&amp;rft.aufirst=Andrew&amp;rft.aulast=Pollack&amp;rft.date=2015-09-20&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2015%2F09%2F21%2Fbusiness%2Fa-huge-overnight-increase-in-a-drugs-price-raises-protests.html&amp;rft.jtitle=The+New+York+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-PMID24585567-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-PMID24585567_59-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Masur H, Brooks JT, Benson CA, Holmes KK (Feb 2014). "Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.". <i>Clin Infect Dis</i>. <b>58</b> (9): 1308–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a class="external text" href="//dx.doi.org/10.1093%2Fcid%2Fciu094" rel="nofollow">10.1093/cid/ciu094</a>. <a class="mw-redirect" href="/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a> <a class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24585567" rel="nofollow">24585567</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Prevention+and+treatment+of+opportunistic+infections+in+HIV-infected+adults+and+adolescents%3A+Updated+Guidelines+from+the+Centers+for+Disease+Control+and+Prevention%2C+National+Institutes+of+Health%2C+and+HIV+Medicine+Association+of+the+Infectious+Diseases+Society+of+America.&amp;rft.au=Benson%2C+CA&amp;rft.au=Brooks%2C+JT&amp;rft.aufirst=H&amp;rft.au=Holmes%2C+KK&amp;rft.aulast=Masur&amp;rft.date=2014-02&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fcid%2Fciu094&amp;rft_id=info%3Apmid%2F24585567&amp;rft.issue=9&amp;rft.jtitle=Clin+Infect+Dis&amp;rft.pages=1308-11&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=58"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-MuoioHelio150917-60"><span class="mw-cite-backlink">^ <a href="#cite_ref-MuoioHelio150917_60-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MuoioHelio150917_60-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MuoioHelio150917_60-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Muoio, Dave (September 17, 2015). <a class="external text" href="http://www.healio.com/infectious-disease/hiv-aids/news/online/%7B745d9cc5-df37-4139-b1ac-6dde7b8ae463%7D/daraprim-price-jump-raises-concerns-among-id-groups-providers" rel="nofollow">"Infectious Disease News: Daraprim price jump raises concerns among ID groups, providers"</a>. <i>Healio</i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Infectious+Disease+News%3A+Daraprim+price+jump+raises+concerns+among+ID+groups%2C+providers&amp;rft.aufirst=Dave&amp;rft.aulast=Muoio&amp;rft.date=2015-09-17&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.healio.com%2Finfectious-disease%2Fhiv-aids%2Fnews%2Fonline%2F%257B745d9cc5-df37-4139-b1ac-6dde7b8ae463%257D%2Fdaraprim-price-jump-raises-concerns-among-id-groups-providers&amp;rft.jtitle=Healio&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text">Tirrell, Meg (December 1, 2015). <a class="external text" href="http://www.cnbc.com/2015/11/30/express-scripts-imprimis-to-offer-daraprim-alternative.html" rel="nofollow">"Express Scripts, Imprimis to offer $1 Daraprim alternative"</a>, CNBC, November 30, 2015. Retrieved December 23, 2015.</span></li>
<li id="cite_note-HealioExpln-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-HealioExpln_62-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.healio.com/footer/healio-dot-com/about-healio" rel="nofollow">"About Healio"</a>. <i>Healio</i>. December 10, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=About+Healio&amp;rft.date=2015-12-10&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.healio.com%2Ffooter%2Fhealio-dot-com%2Fabout-healio&amp;rft.jtitle=Healio&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-hivma-63"><span class="mw-cite-backlink">^ <a href="#cite_ref-hivma_63-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-hivma_63-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Calderwood, Stephen B.; Adimora, Adaora (September 8, 2015). <a class="external text" href="http://www.hivma.org/uploadedFiles/HIVMA/HomePageContent/PyrimethamineLetter.pdf" rel="nofollow">"Letter from Stephen B. Calderwood, MD, FIDSA (President, IDSA) and Adaora Adimora, MD, MPH, FIDSA (Chair, HIVMA) to Mssrs. Tom Evegan (Head of Managed Markets) and Kevin Bernier (National Director Alliance Development &amp; Public Affairs), both of Turing Pharmaceuticals"</a> <span style="font-size:85%;">(PDF)</span>. Arlington, Virginia: Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA)<span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.au=Adimora%2C+Adaora&amp;rft.aufirst=Stephen+B.&amp;rft.aulast=Calderwood&amp;rft.btitle=Letter+from+Stephen+B.+Calderwood%2C+MD%2C+FIDSA+%28President%2C+IDSA%29+and+Adaora+Adimora%2C+MD%2C+MPH%2C+FIDSA+%28Chair%2C+HIVMA%29+to+Mssrs.+Tom+Evegan+%28Head+of+Managed+Markets%29+and+Kevin+Bernier+%28National+Director+Alliance+Development+%26+Public+Affairs%29%2C+both+of+Turing+Pharmaceuticals&amp;rft.date=2015-09-08&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.hivma.org%2FuploadedFiles%2FHIVMA%2FHomePageContent%2FPyrimethamineLetter.pdf&amp;rft.place=Arlington%2C+Virginia&amp;rft.pub=Infectious+Diseases+Society+of+America+%28IDSA%29%2C+HIV+Medicine+Association+%28HIVMA%29&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-CorrectPercent-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-CorrectPercent_64-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Kliff, Sarah (September 22, 2015). <a class="external text" href="http://www.vox.com/2015/9/22/9366721/daraprim-price-shkreli-turing" rel="nofollow">"Vox Explainers: A Drug Company Raised a Pill's Price 5,500 Percent Because, in America, It Can"</a>. <i><a href="/wiki/Vox_(website)" title="Vox (website)">Vox</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 9,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Vox+Explainers%3A+A+Drug+Company+Raised+a+Pill%27s+Price+5%2C500+Percent+Because%2C+in+America%2C+It+Can&amp;rft.aufirst=Sarah&amp;rft.aulast=Kliff&amp;rft.date=2015-09-22&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.vox.com%2F2015%2F9%2F22%2F9366721%2Fdaraprim-price-shkreli-turing&amp;rft.jtitle=Vox&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-BloombergTargeted-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-BloombergTargeted_65-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Bloomfield, Doni (September 22, 2015). <a class="external text" href="http://www.bloomberg.com/news/articles/2015-09-22/big-pharma-lobby-group-forswears-drugmaker-targeted-by-clinton" rel="nofollow">"Drug CEO Targeted by Clinton Is Criticized by Drug Lobby"</a>. <i>Bloomberg Businessweek</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0007-7135" rel="nofollow">0007-7135</a><span class="reference-accessdate">. Retrieved <span class="nowrap">September 23,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Drug+CEO+Targeted+by+Clinton+Is+Criticized+by+Drug+Lobby&amp;rft.aufirst=Doni&amp;rft.aulast=Bloomfield&amp;rft.date=2015-09-22&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2015-09-22%2Fbig-pharma-lobby-group-forswears-drugmaker-targeted-by-clinton&amp;rft.issn=0007-7135&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-CNNMeet-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-CNNMeet_66-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Long, Heather; Egan, Matt; Dodley, Dominique (September 22, 2015). <a class="external text" href="http://money.cnn.com/2015/09/22/investing/aids-drug-martin-shkreli-750-cancer-drug" rel="nofollow">"Meet the guy behind the $750 AIDS drug"</a>. CNN<span class="reference-accessdate">. Retrieved <span class="nowrap">September 23,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.au=Dodley%2C+Dominique&amp;rft.au=Egan%2C+Matt&amp;rft.aufirst=Heather&amp;rft.aulast=Long&amp;rft.btitle=Meet+the+guy+behind+the+%24750+AIDS+drug&amp;rft.date=2015-09-22&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fmoney.cnn.com%2F2015%2F09%2F22%2Finvesting%2Faids-drug-martin-shkreli-750-cancer-drug&amp;rft.pub=CNN&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-WaPoMoron-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-WaPoMoron_67-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Eunjung Cha, Ariana (September 22, 2015). <a class="external text" href="https://www.washingtonpost.com/news/to-your-health/wp/2015/09/21/ceo-of-company-that-raised-the-price-of-old-pill-hundreds-of-dollars-overnight-calls-journalist-a-moron-for-asking-why" rel="nofollow">"CEO who raised price of old pill more than $700 calls journalist a 'moron' for asking why"</a>. <i><a href="/wiki/The_Washington_Post" title="The Washington Post">The Washington Post</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">September 23,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=CEO+who+raised+price+of+old+pill+more+than+%24700+calls+journalist+a+%27moron%27+for+asking+why&amp;rft.aufirst=Ariana&amp;rft.aulast=Eunjung+Cha&amp;rft.date=2015-09-22&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fnews%2Fto-your-health%2Fwp%2F2015%2F09%2F21%2Fceo-of-company-that-raised-the-price-of-old-pill-hundreds-of-dollars-overnight-calls-journalist-a-moron-for-asking-why&amp;rft.jtitle=The+Washington+Post&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-trump_bi-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-trump_bi_68-0">^</a></b></span> <span class="reference-text"><cite class="citation web">LoGiurato, Brett. <a class="external text" href="http://www.businessinsider.com/donald-trump-martin-shkreli-daraprim-drug-cost-2015-9" rel="nofollow">"Donald Trump trashes former hedge-fund guy who jacked up drug price: 'He looks like a spoiled brat<span style="padding-right:0.2em;">'</span>"</a>. <i>Business Insider</i><span class="reference-accessdate">. Retrieved <span class="nowrap">September 23,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Donald+Trump+trashes+former+hedge-fund+guy+who+jacked+up+drug+price%3A+%27He+looks+like+a+spoiled+brat%27&amp;rft.aufirst=Brett&amp;rft.aulast=LoGiurato&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.businessinsider.com%2Fdonald-trump-martin-shkreli-daraprim-drug-cost-2015-9&amp;rft.jtitle=Business+Insider&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><cite class="citation audio-visual">Tirrell, Meg (October 22, 2015). <a class="external text" href="http://video.cnbc.com/gallery/?video=3000437256" rel="nofollow"><i>Health Groups Appeal to Turing on Drug Price (October 22, 2015)</i></a> (news video). Englewood Cliffs, New Jersey: <a href="/wiki/CNBC" title="CNBC">CNBC</a><span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.btitle=Health+Groups+Appeal+to+Turing+on+Drug+Price+%28October+22%2C+2015%29&amp;rft.date=2015-10-22&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fvideo.cnbc.com%2Fgallery%2F%3Fvideo%3D3000437256&amp;rft.place=Englewood+Cliffs%2C+New+Jersey&amp;rft.pub=CNBC&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-IDSAopenLttr-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-IDSAopenLttr_70-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://idsocietyorg.app.box.com/TuringOpenLetter" rel="nofollow">"An Open Appeal to Turing Pharmaceuticals"</a>. Arlington, Virginia: Infectious Diseases Society of America (IDSA). November 3, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.btitle=An+Open+Appeal+to+Turing+Pharmaceuticals&amp;rft.date=2015-11-03&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fidsocietyorg.app.box.com%2FTuringOpenLetter&amp;rft.place=Arlington%2C+Virginia&amp;rft.pub=Infectious+Diseases+Society+of+America+%28IDSA%29&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><cite class="citation web">Walters, Joanna (September 25, 2015). <a class="external text" href="https://www.theguardian.com/business/2015/sep/25/record-label-cuts-ties-hedge-fund-boosted-aids-drug-price-martin-shkreli" rel="nofollow">"Music Industry: Label Cuts Ties With Hedge Fund Man Who Boosted AIDS Drug Price 5,000%"</a>. <i>The Guardian</i><span class="reference-accessdate">. Retrieved <span class="nowrap">September 28,</span> 2015</span>. <q>Subtitle: Collect Records says it is impossible to continue having Martin Shkreli as investor over raising Daraprim price from $13.50 per tablet to $750.</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Music+Industry%3A+Label+Cuts+Ties+With+Hedge+Fund+Man+Who+Boosted+AIDS+Drug+Price+5%2C000%25&amp;rft.aufirst=Joanna&amp;rft.aulast=Walters&amp;rft.date=2015-09-25&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fbusiness%2F2015%2Fsep%2F25%2Frecord-label-cuts-ties-hedge-fund-boosted-aids-drug-price-martin-shkreli&amp;rft.jtitle=The+Guardian&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Fu2015-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-Fu2015_72-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Fu, Scarlet (September 21, 2015). <a class="external text" href="http://www.bloomberg.com/news/videos/2015-09-21/why-turing-increased-price-of-daraprim-over-500-" rel="nofollow">"Drug Goes From $13.50 to $750 Overnight [interview]"</a>. Bloomberg<span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.aufirst=Scarlet&amp;rft.aulast=Fu&amp;rft.btitle=Drug+Goes+From+%2413.50+to+%24750+Overnight+%26%2391%3Binterview%26%2393%3B&amp;rft.date=2015-09-21&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2Fvideos%2F2015-09-21%2Fwhy-turing-increased-price-of-daraprim-over-500-&amp;rft.pub=Bloomberg&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Ramsey_Aston_Martin-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ramsey_Aston_Martin_73-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Ramsey, Lydia (September 22, 2015). <a class="external text" href="http://www.businessinsider.com/martin-shkreli-defends-daraprim-price-2015-9" rel="nofollow">"A pharma CEO tried to defend his decision to jack up the price of a critical drug by 5,000% – and it backfired"</a>. <i>Business Insider</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=A+pharma+CEO+tried+to+defend+his+decision+to+jack+up+the+price+of+a+critical+drug+by+5%2C000%25+%93+and+it+backfired&amp;rft.aufirst=Lydia&amp;rft.aulast=Ramsey&amp;rft.date=2015-09-22&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.businessinsider.com%2Fmartin-shkreli-defends-daraprim-price-2015-9&amp;rft.jtitle=Business+Insider&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Aston_Martin_Reuters-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-Aston_Martin_Reuters_74-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="http://uk.reuters.com/video/2015/09/22/company-hikes-price-of-popular-drug?videoId=365682609" rel="nofollow">"Company hikes price of popular drug"</a>. Reuters. September 22, 2015.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Company+hikes+price+of+popular+drug&amp;rft.date=2015-09-22&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fuk.reuters.com%2Fvideo%2F2015%2F09%2F22%2Fcompany-hikes-price-of-popular-drug%3FvideoId%3D365682609&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Pollack2015b-75"><span class="mw-cite-backlink">^ <a href="#cite_ref-Pollack2015b_75-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Pollack2015b_75-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Pollack, Andrew (November 24, 2015). <a class="external text" href="http://www.nytimes.com/2015/11/25/business/turing-refuses-to-lower-list-price-of-toxoplasmosis-drug.html" rel="nofollow">"Turing Refuses to Lower List Price of Toxoplasmosis Drug"</a>. <i>The New York Times</i>. p. B4. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0362-4331" rel="nofollow">0362-4331</a>. <a class="external text" href="https://web.archive.org/web/20151125035228/www.nytimes.com/2015/11/25/business/turing-refuses-to-lower-list-price-of-toxoplasmosis-drug.html" rel="nofollow">Archived</a> from the original on November 25, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">February 7,</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Turing+Refuses+to+Lower+List+Price+of+Toxoplasmosis+Drug&amp;rft.aufirst=Andrew&amp;rft.aulast=Pollack&amp;rft.date=2015-11-24&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2015%2F11%2F25%2Fbusiness%2Fturing-refuses-to-lower-list-price-of-toxoplasmosis-drug.html&amp;rft.issn=0362-4331&amp;rft.jtitle=The+New+York+Times&amp;rft.pages=B4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text">Ramsey Lydia (October 12, 2015). <a class="external text" href="http://www.businessinsider.com/martin-shkreli-never-responded-to-bernie-sanders-about-turing-2015-10" rel="nofollow">"Pharma CEO Martin Shkreli failed to respond to Bernie Sanders about his drug hike – and Sanders is not happy"</a>. <i>Business Insider</i>.</span></li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><cite class="citation web"><a href="/wiki/Bernie_Sanders" title="Bernie Sanders">Sanders, Bernie</a> (September 21, 2015). <a class="external text" href="http://democrats.oversight.house.gov/sites/democrats.oversight.house.gov/files/documents/2015-09-21%20EEC%20Sanders%20to%20Turing%20Pharmaceuticals.pdf" rel="nofollow">"2015-09-01 EEC Sanders to Turing Pharmaceuticals"</a> <span style="font-size:85%;">(PDF)</span>. <i><a href="/wiki/United_States_House_Committee_on_Oversight_and_Government_Reform" title="United States House Committee on Oversight and Government Reform">United States House Committee on Oversight and Government Reform</a> (Democratic Party)</i><span class="reference-accessdate">. Retrieved <span class="nowrap">October 9,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=2015-09-01+EEC+Sanders+to+Turing+Pharmaceuticals&amp;rft.aufirst=Bernie&amp;rft.aulast=Sanders&amp;rft.date=2015-09-21&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fdemocrats.oversight.house.gov%2Fsites%2Fdemocrats.oversight.house.gov%2Ffiles%2Fdocuments%2F2015-09-21%2520EEC%2520Sanders%2520to%2520Turing%2520Pharmaceuticals.pdf&amp;rft.jtitle=United+States+House+Committee+on+Oversight+and+Government+Reform+%28Democratic+Party%29&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><cite class="citation web">Wilson, Megan R. (October 2, 2015). <a class="external text" href="http://thehill.com/business-a-lobbying/255760-drug-firm-maligned-for-price-hike-turns-to-k-street-for-help" rel="nofollow">"Business &amp; Lobbying: Drug firm maligned for 5,000 percent price hike turns to K Street for help"</a>. <i><a href="/wiki/The_Hill_(newspaper)" title="The Hill (newspaper)">The Hill</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 9,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Business+%26+Lobbying%3A+Drug+firm+maligned+for+5%2C000+percent+price+hike+turns+to+K+Street+for+help&amp;rft.aufirst=Megan+R.&amp;rft.aulast=Wilson&amp;rft.date=2015-10-02&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fthehill.com%2Fbusiness-a-lobbying%2F255760-drug-firm-maligned-for-price-hike-turns-to-k-street-for-help&amp;rft.jtitle=The+Hill&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Ho2015-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ho2015_79-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Ho, Catherine (October 7, 2015). <a class="external text" href="https://www.washingtonpost.com/news/powerpost/wp/2015/10/07/working-for-the-most-hated-man-in-america" rel="nofollow">"Working For 'The Most Hated Man in America<span style="padding-right:0.2em;">'</span>"</a>. <i><a href="/wiki/The_Washington_Post" title="The Washington Post">The Washington Post</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Working+For+%27The+Most+Hated+Man+in+America%27&amp;rft.aufirst=Catherine&amp;rft.aulast=Ho&amp;rft.date=2015-10-07&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fnews%2Fpowerpost%2Fwp%2F2015%2F10%2F07%2Fworking-for-the-most-hated-man-in-america&amp;rft.jtitle=The+Washington+Post&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Martin_Shkreli-Ripp-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-Martin_Shkreli-Ripp_80-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Tannahill, Jason (October 9, 2015). <a class="external text" href="http://everything-pr.com/allan-ripp-represents-martin-shkreli/69517" rel="nofollow">"PR Man Allan Ripp Representing The 'Most Hated Man in America<span style="padding-right:0.2em;">'</span>"</a>. EverythingPR.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.aufirst=Jason&amp;rft.aulast=Tannahill&amp;rft.btitle=PR+Man+Allan+Ripp+Representing+The+%27Most+Hated+Man+in+America%27&amp;rft.date=2015-10-09&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Feverything-pr.com%2Fallan-ripp-represents-martin-shkreli%2F69517&amp;rft.pub=EverythingPR&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-FoxMaggieNBC151022-81"><span class="mw-cite-backlink">^ <a href="#cite_ref-FoxMaggieNBC151022_81-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FoxMaggieNBC151022_81-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Fox, Maggie (October 22, 2015). <a class="external text" href="http://www.nbcnews.com/health/health-news/competitor-offer-1-pill-after-turing-price-hike-outrage-n449661" rel="nofollow">"Health: Competitor to Offer $1 Pill After Turing Price Hike Outrage"</a>. NBC News<span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.aufirst=Maggie&amp;rft.aulast=Fox&amp;rft.btitle=Health%3A+Competitor+to+Offer+%241+Pill+After+Turing+Price+Hike+Outrage&amp;rft.date=2015-10-22&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.nbcnews.com%2Fhealth%2Fhealth-news%2Fcompetitor-offer-1-pill-after-turing-price-hike-outrage-n449661&amp;rft.pub=NBC+News&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><cite class="citation web">Langreth, Robert (November 24, 2015). <a class="external text" href="http://www.bloomberg.com/news/articles/2015-11-24/drugmaker-turing-suggests-it-won-t-cut-list-price-of-daraprim" rel="nofollow">"Drugmaker Turing Suggests It Won't Cut List Price of Daraprim"</a>. <i>Bloomberg Businessweek</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0007-7135" rel="nofollow">0007-7135</a><span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Drugmaker+Turing+Suggests+It+Won%27t+Cut+List+Price+of+Daraprim&amp;rft.aufirst=Robert&amp;rft.aulast=Langreth&amp;rft.date=2015-11-24&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2015-11-24%2Fdrugmaker-turing-suggests-it-won-t-cut-list-price-of-daraprim&amp;rft.issn=0007-7135&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="http://www.washingtonpost.com/business/economy/turing-reneges-on-drug-price-cut-rivals-version-sells-well/2015/11/25/d2c22bd8-93cd-11e5-b5e4-279b4501e8a6_story.html" rel="nofollow">"Business: Turing Reneges on Drug Price Cut, Rival's Version Sells Well"</a>. <i><a href="/wiki/The_Washington_Post" title="The Washington Post">The Washington Post</a></i>. <a href="/wiki/Associated_Press" title="Associated Press">Associated Press</a>. November 25, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">November 27,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Business%3A+Turing+Reneges+on+Drug+Price+Cut%2C+Rival%27s+Version+Sells+Well&amp;rft.date=2015-11-25&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.washingtonpost.com%2Fbusiness%2Feconomy%2Fturing-reneges-on-drug-price-cut-rivals-version-sells-well%2F2015%2F11%2F25%2Fd2c22bd8-93cd-11e5-b5e4-279b4501e8a6_story.html&amp;rft.jtitle=The+Washington+Post&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://finance.yahoo.com/news/kalobios-stock-rockets-investment-shkreli-194805694.html" rel="nofollow">"KaloBios stock rockets after investment from Shkreli"</a>. <i>Yahoo Finance</i>. November 19, 2015.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=KaloBios+stock+rockets+after+investment+from+Shkreli&amp;rft.date=2015-11-19&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Ffinance.yahoo.com%2Fnews%2Fkalobios-stock-rockets-investment-shkreli-194805694.html&amp;rft.jtitle=Yahoo+Finance&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://ir.kalobios.com/releasedetail.cfm?ReleaseID=943772" rel="nofollow">"KaloBios Pharmaceuticals, Inc. Appoints Martin Shkreli CEO and Announces New Financing"</a>. <i>Kalobios</i>. November 19, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">December 18,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=KaloBios+Pharmaceuticals%2C+Inc.+Appoints+Martin+Shkreli+CEO+and+Announces+New+Financing&amp;rft.date=2015-11-19&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fir.kalobios.com%2Freleasedetail.cfm%3FReleaseID%3D943772&amp;rft.jtitle=Kalobios&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><cite class="citation web">Weintraub, Arlene (November 19, 2015). <a class="external text" href="http://www.forbes.com/sites/arleneweintraub/2015/11/19/heres-why-shkreli-is-going-to-have-his-hands-full-trying-to-save-kalobios" rel="nofollow">"Here's Why Shkreli Is Going To Have His Hands Full Trying To Save KaloBios"</a>. <i>Forbes</i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Here%27s+Why+Shkreli+Is+Going+To+Have+His+Hands+Full+Trying+To+Save+KaloBios&amp;rft.aufirst=Arlene&amp;rft.aulast=Weintraub&amp;rft.date=2015-11-19&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.forbes.com%2Fsites%2Farleneweintraub%2F2015%2F11%2F19%2Fheres-why-shkreli-is-going-to-have-his-hands-full-trying-to-save-kalobios&amp;rft.jtitle=Forbes&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><cite class="citation web">Rosenfeld, Everett (December 21, 2015). <a class="external text" href="http://www.cnbc.com/2015/12/21/martin-shkreli-fired-as-ceo-of-kalobios-pharmaceuticals.html" rel="nofollow">"Martin Shkreli fired by KaloBios Pharmaceuticals"</a>. CNBC<span class="reference-accessdate">. Retrieved <span class="nowrap">December 21,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.aufirst=Everett&amp;rft.aulast=Rosenfeld&amp;rft.btitle=Martin+Shkreli+fired+by+KaloBios+Pharmaceuticals&amp;rft.date=2015-12-21&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.cnbc.com%2F2015%2F12%2F21%2Fmartin-shkreli-fired-as-ceo-of-kalobios-pharmaceuticals.html&amp;rft.pub=CNBC&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-cnbc-chap-11-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-cnbc-chap-11_88-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="http://www.cnbc.com/2015/12/30/kalobios-pharmaceuticals-files-for-bankruptcy.html" rel="nofollow">"Martin Shkreli's KaloBios files for bankruptcy"</a>. CNBC. Reuters. December 30, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">December 30,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli%27s+KaloBios+files+for+bankruptcy&amp;rft.date=2015-12-30&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cnbc.com%2F2015%2F12%2F30%2Fkalobios-pharmaceuticals-files-for-bankruptcy.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text"><cite class="citation web">Smythe, Christie; Geiger, Keri (December 17, 2015). <a class="external text" href="http://www.bloomberg.com/features/2015-martin-shkreli-securities-fraud" rel="nofollow">"Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges"</a>. <i>Bloomberg Businessweek</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0007-7135" rel="nofollow">0007-7135</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Shkreli%2C+CEO+Reviled+for+Drug+Price+Gouging%2C+Arrested+on+Securities+Fraud+Charges&amp;rft.aufirst=Christie&amp;rft.au=Geiger%2C+Keri&amp;rft.aulast=Smythe&amp;rft.date=2015-12-17&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Ffeatures%2F2015-martin-shkreli-securities-fraud&amp;rft.issn=0007-7135&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><a class="external text" href="http://www.justice.gov/usao-edny/pr/former-hedge-fund-manager-and-new-york-attorney-indicted-multimillion-dollar-fraud" rel="nofollow">Former Hedge Fund Manager and New York Attorney Indicted in Multimillion Dollar Fraud Scheme</a>, <a class="mw-redirect" href="/wiki/U.S._Attorney%27s_Office" title="U.S. Attorney's Office">U.S. Attorney's Office</a>, Eastern District of New York, <a href="/wiki/United_States_Department_of_Justice" title="United States Department of Justice">United States Department of Justice</a>, December 17, 2015.</span></li>
<li id="cite_note-Grim2015-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-Grim2015_91-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Grim, Ryan; Young, Jeffrey (September 23, 2016) [1st pub. September 22, 2015]. <a class="external text" href="http://www.huffingtonpost.com/entry/martin-shkreli-sec-investigation_us_5601a3c4e4b08820d91a6b6f" rel="nofollow">"Drug‑Price Gouging Hedge Fund Guy May Be Even Worse Than You Thought, SEC Documents Show"</a>. <a class="external text" href="https://web.archive.org/web/20151220155823/www.huffingtonpost.com/entry/martin-shkreli-sec-investigation_5601a3c4e4b08820d91a6b6f" rel="nofollow">Archived</a> from the original on December 20, 2015.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.aufirst=Ryan&amp;rft.aulast=Grim&amp;rft.au=Young%2C+Jeffrey&amp;rft.btitle=Drug%91Price+Gouging+Hedge+Fund+Guy+May+Be+Even+Worse+Than+You+Thought%2C+SEC+Documents+Show&amp;rft.date=2016-09-23&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.huffingtonpost.com%2Fentry%2Fmartin-shkreli-sec-investigation_us_5601a3c4e4b08820d91a6b6f&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Copeland2015-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-Copeland2015_92-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Copeland, Rob. <a class="external text" href="http://www.wsj.com/articles/martin-shkreli-says-drug-price-hikes-led-to-arrest-1450671884" rel="nofollow">"Martin Shkreli Says Drug-Price Hikes Led to Arrest"</a>. <i>The Wall Street Journal</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0099-9660" rel="nofollow">0099-9660</a><span class="reference-accessdate">. Retrieved <span class="nowrap">December 21,</span> 2015</span>. <span style="font-size:90%; color:#555">(subscription required (<span style="border-bottom:1px dotted;cursor:help" title="Sources are not required to be available online. Online sources do not have to be freely available. The site may require a paid subscription.">help</span>))</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli+Says+Drug-Price+Hikes+Led+to+Arrest&amp;rft.aufirst=Rob&amp;rft.aulast=Copeland&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.wsj.com%2Farticles%2Fmartin-shkreli-says-drug-price-hikes-led-to-arrest-1450671884&amp;rft.issn=0099-9660&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Reich2015-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-Reich2015_93-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Reich, Robert (December 24, 2015). <a class="external text" href="http://www.sfgate.com/opinion/reich/article/Shkreli-con-man-or-just-a-brasher-corporate-6717908.php" rel="nofollow">"Opinion: Shkreli: sociopath or just extra-brash corporate exec?"</a>. <i>San Francisco Chronicle</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/1932-8672" rel="nofollow">1932-8672</a>. <a class="external text" href="https://web.archive.org/web/20160206153353/www.sfgate.com/opinion/reich/article/Shkreli-con-man-or-just-a-brasher-corporate-6717908.php" rel="nofollow">Archived</a> from the original on February 6, 2016. <q>So what, exactly, did Martin Shkreli do wrong, by the standards of today’s capitalism? He played the same game many others are playing on Wall Street and in corporate suites. He was just more audacious about it.</q></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Opinion%3A+Shkreli%3A+sociopath+or+just+extra-brash+corporate+exec%3F&amp;rft.aufirst=Robert&amp;rft.aulast=Reich&amp;rft.date=2015-12-24&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.sfgate.com%2Fopinion%2Freich%2Farticle%2FShkreli-con-man-or-just-a-brasher-corporate-6717908.php&amp;rft.issn=1932-8672&amp;rft.jtitle=San+Francisco+Chronicle&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Goldstein2016-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-Goldstein2016_94-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Goldstein, Matthew; Stevenson, Alexandra (February 3, 2016). <a class="external text" href="http://www.nytimes.com/2016/02/04/business/martin-shkreli-appears-to-adopt-a-new-legal-strategy-silence.html" rel="nofollow">"Martin Shkreli Appears to Adopt a New Legal Strategy: Silence"</a>. <i>The New York Times</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0362-4331" rel="nofollow">0362-4331</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli+Appears+to+Adopt+a+New+Legal+Strategy%3A+Silence&amp;rft.aufirst=Matthew&amp;rft.aulast=Goldstein&amp;rft.au=Stevenson%2C+Alexandra&amp;rft.date=2016-02-03&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2016%2F02%2F04%2Fbusiness%2Fmartin-shkreli-appears-to-adopt-a-new-legal-strategy-silence.html&amp;rft.issn=0362-4331&amp;rft.jtitle=The+New+York+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Silverstein2016-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-Silverstein2016_95-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Silverstein, Jason (February 2, 2016). <a class="external text" href="http://www.nydailynews.com/news/national/martin-shkreli-hires-famed-defense-attorney-benjamin-brafman-article-1.2517398" rel="nofollow">"Martin Shkreli hires Benjamin Brafman, high‑profile attorney who defended Sean Combs, Michael Jackson and Dominique Strauss‑Kahn"</a>. <i>Daily News</i>. New York. <a href="/wiki/Library_of_Congress_Control_Number" title="Library of Congress Control Number">LCCN</a> <a class="external text" href="//lccn.loc.gov/sn83030450" rel="nofollow">sn83030450</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli+hires+Benjamin+Brafman%2C+high%91profile+attorney+who+defended+Sean+Combs%2C+Michael+Jackson+and+Dominique+Strauss%91Kahn&amp;rft.aufirst=Jason&amp;rft.aulast=Silverstein&amp;rft.date=2016-02-02&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.nydailynews.com%2Fnews%2Fnational%2Fmartin-shkreli-hires-famed-defense-attorney-benjamin-brafman-article-1.2517398&amp;rft_id=info%3Alccn%2Fsn83030450&amp;rft.jtitle=Daily+News&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-JohnsonWaPo-96"><span class="mw-cite-backlink">^ <a href="#cite_ref-JohnsonWaPo_96-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-JohnsonWaPo_96-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-JohnsonWaPo_96-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Carolyn Y. Johnson, <a class="external text" href="https://www.washingtonpost.com/news/wonk/wp/2016/02/04/pharma-bro-martin-shkreli-faces-congress-today-but-pledges-silence/" rel="nofollow">'Pharma bro' Martin Shkreli refuses to testify at congressional hearing, calls lawmakers 'imbeciles' in tweet</a>, <i>The Washington Post</i> (February 4, 2015).</span></li>
<li id="cite_note-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-97">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://oversight.house.gov/hearing/developments-in-the-prescription-drug-market-oversight/" rel="nofollow">"Developments in the Prescription Drug Market: Oversight - United States House Committee on Oversight and Government Reform"</a>. Oversight.house.gov<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-02-07</span></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.btitle=Developments+in+the+Prescription+Drug+Market%3A+Oversight+-+United+States+House+Committee+on+Oversight+and+Government+Reform&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Foversight.house.gov%2Fhearing%2Fdevelopments-in-the-prescription-drug-market-oversight%2F&amp;rft.pub=Oversight.house.gov&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://oversight.house.gov/wp-content/uploads/2016/02/Retzlaff-Turing-Statement-1-26-Prescription-Drugs.pdf" rel="nofollow">"TESTIMONY OF NANCY RETZLAFF CHIEF COMMERCIAL OFFICER, TURING PHARMACEUTICALS"</a> <span style="font-size:85%;">(PDF)</span>. <i>oversight.house.gov</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=TESTIMONY+OF+NANCY+RETZLAFF+CHIEF+COMMERCIAL+OFFICER%2C+TURING+PHARMACEUTICALS&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Foversight.house.gov%2Fwp-content%2Fuploads%2F2016%2F02%2FRetzlaff-Turing-Statement-1-26-Prescription-Drugs.pdf&amp;rft.jtitle=oversight.house.gov&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-99">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://oversight.house.gov/wp-content/uploads/2016/02/Schiller-Valeant-Statement-1-26-Prescription-Drugs.pdf" rel="nofollow">"Statement of Howard B. Schiller Interim Chief Executive Officer and Director, Valeant Pharmaceuticals International, Inc."</a> <span style="font-size:85%;">(PDF)</span>. <i>oversight.house.gov</i>. February 4, 2016.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Statement+of+Howard+B.+Schiller+Interim+Chief+Executive+Officer+and+Director%2C+Valeant+Pharmaceuticals+International%2C+Inc.&amp;rft.date=2016-02-04&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Foversight.house.gov%2Fwp-content%2Fuploads%2F2016%2F02%2FSchiller-Valeant-Statement-1-26-Prescription-Drugs.pdf&amp;rft.jtitle=oversight.house.gov&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="https://www.theguardian.com/business/2016/feb/04/martin-shkreli-refuses-to-testify-congress-drug-daraprim" rel="nofollow">"Drug company boss Martin Shkreli refuses to testify to Congress"</a>. <i>oversight.house.gov</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Drug+company+boss+Martin+Shkreli+refuses+to+testify+to+Congress&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fbusiness%2F2016%2Ffeb%2F04%2Fmartin-shkreli-refuses-to-testify-congress-drug-daraprim&amp;rft.jtitle=oversight.house.gov&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.slate.com/blogs/moneybox/2016/02/04/martin_shkreli_trolls_congress_by_refusing_to_answer_questions.html" rel="nofollow">"Watch Martin Shkreli Troll Congress by Taking the Fifth Over and Over Again"</a>. <i>MoneyBox</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Watch+Martin+Shkreli+Troll+Congress+by+Taking+the+Fifth+Over+and+Over+Again&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.slate.com%2Fblogs%2Fmoneybox%2F2016%2F02%2F04%2Fmartin_shkreli_trolls_congress_by_refusing_to_answer_questions.html&amp;rft.jtitle=MoneyBox&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Leonard2015-102"><span class="mw-cite-backlink">^ <a href="#cite_ref-Leonard2015_102-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Leonard2015_102-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Leonard, David; Hordern, Annmarie (December 9, 2015). <a class="external text" href="http://www.bloomberg.com/features/2015-martin-shkreli-wu-tang-clan-album" rel="nofollow">"Who Bought The Most Expensive Album Ever Made?"</a>. <i>Bloomberg Businessweek</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0007-7135" rel="nofollow">0007-7135</a><span class="reference-accessdate">. Retrieved <span class="nowrap">December 10,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Who+Bought+The+Most+Expensive+Album+Ever+Made%3F&amp;rft.aufirst=David&amp;rft.au=Hordern%2C+Annmarie&amp;rft.aulast=Leonard&amp;rft.date=2015-12-09&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.bloomberg.com%2Ffeatures%2F2015-martin-shkreli-wu-tang-clan-album&amp;rft.issn=0007-7135&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Pollack2016-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-Pollack2016_103-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Pollack, Andrew; Huetteman, Emmarie (February 4, 2016). <a class="external text" href="http://www.nytimes.com/2016/02/05/business/drug-prices-valeant-martin-shkreli-congress.html" rel="nofollow">"Martin Shkreli Invokes the Fifth Amendment During Grilling by Congress"</a>. <i>The New York Times</i>. p. B1. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/0362-4331" rel="nofollow">0362-4331</a>. <a class="external text" href="http://webcitation.org/query?date=2016-02-10&amp;url=http%3A%2F%2Fwww.nytimes.com%2F2016%2F02%2F05%2Fbusiness%2Fdrug-prices-valeant-martin-shkreli-congress.html" rel="nofollow">Archived</a> from the original on February 10, 2016.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli+Invokes+the+Fifth+Amendment+During+Grilling+by+Congress&amp;rft.aufirst=Andrew&amp;rft.au=Huetteman%2C+Emmarie&amp;rft.aulast=Pollack&amp;rft.date=2016-02-04&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2016%2F02%2F05%2Fbusiness%2Fdrug-prices-valeant-martin-shkreli-congress.html&amp;rft.issn=0362-4331&amp;rft.jtitle=The+New+York+Times&amp;rft.pages=B1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-104">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.mcclatchydc.com/news/politics-government/congress/article59002788.html" rel="nofollow">"Shkreli didn't say much to Congress, but he talked non-stop afterward"</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.btitle=Shkreli+didn%99t+say+much+to+Congress%2C+but+he+talked+non-stop+afterward&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.mcclatchydc.com%2Fnews%2Fpolitics-government%2Fcongress%2Farticle59002788.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-105">^</a></b></span> <span class="reference-text"><cite class="citation web">Wolf, Jacob (May 6, 2015). <a class="external text" href="http://www.dailydot.com/esports/shkreli-challenger-inori-curryshotgg/" rel="nofollow">"Millionaire pharmaceutical CEO set to shake up Challenger scene with new team"</a>. <i><a href="/wiki/The_Daily_Dot" title="The Daily Dot">The Daily Dot</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">August 27,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Millionaire+pharmaceutical+CEO+set+to+shake+up+Challenger+scene+with+new+team&amp;rft.aufirst=Jacob&amp;rft.aulast=Wolf&amp;rft.date=2015-05-06&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.dailydot.com%2Fesports%2Fshkreli-challenger-inori-curryshotgg%2F&amp;rft.jtitle=The+Daily+Dot&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-106">^</a></b></span> <span class="reference-text"><cite class="citation web">Weber, Alexandre "Druppet" (May 4, 2015). <a class="external text" href="http://esportsgo.com/enemy-esports-turned-1-2-million-league-legends-team/esports/" rel="nofollow">"Enemy Esports Turned Down $1.2 Million For Their League of Legends Team"</a>. <i>eSports Go</i><span class="reference-accessdate">. Retrieved <span class="nowrap">September 24,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Enemy+Esports+Turned+Down+%241.2+Million+For+Their+League+of+Legends+Team&amp;rft.aufirst=Alexandre+%22Druppet%22&amp;rft.aulast=Weber&amp;rft.date=2015-05-04&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fesportsgo.com%2Fenemy-esports-turned-1-2-million-league-legends-team%2Fesports%2F&amp;rft.jtitle=eSports+Go&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-107">^</a></b></span> <span class="reference-text"><cite class="citation web">Wolf, Jacob (August 7, 2015). <a class="external text" href="http://www.dailydot.com/esports/imagine-odyssey-merger" rel="nofollow">"Imagine and Odyssey merge, add Leviathan Dota 2 squad"</a>. <i>The Daily Dot</i><span class="reference-accessdate">. Retrieved <span class="nowrap">August 27,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Imagine+and+Odyssey+merge%2C+add+Leviathan+Dota+2+squad&amp;rft.aufirst=Jacob&amp;rft.aulast=Wolf&amp;rft.date=2015-08-07&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.dailydot.com%2Fesports%2Fimagine-odyssey-merger&amp;rft.jtitle=The+Daily+Dot&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-108">^</a></b></span> <span class="reference-text"><cite class="citation web">Ciubotaru, Andra (August 18, 2015). <a class="external text" href="http://dotablast.com/recently-merged-league-of-legends-organization-adds-team-leviathan-dota-2-squad/" rel="nofollow">"Recently merged League of Legends organization adds Team Leviathan Dota 2 squad"</a>. <i>DotaBlast</i><span class="reference-accessdate">. Retrieved <span class="nowrap">August 27,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Recently+merged+League+of+Legends+organization+adds+Team+Leviathan+Dota+2+squad&amp;rft.aufirst=Andra&amp;rft.aulast=Ciubotaru&amp;rft.date=2015-08-18&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fdotablast.com%2Frecently-merged-league-of-legends-organization-adds-team-leviathan-dota-2-squad%2F&amp;rft.jtitle=DotaBlast&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.statnews.com/2015/11/12/martin-shkreli-show-reviled-pharma-exec-just-cant-stop-talking/" rel="nofollow">"Martin Shkreli, widely scorned CEO, livestreams his life"</a>. <i>STAT</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli%2C+widely+scorned+CEO%2C+livestreams+his+life&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.statnews.com%2F2015%2F11%2F12%2Fmartin-shkreli-show-reviled-pharma-exec-just-cant-stop-talking%2F&amp;rft.jtitle=STAT&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><cite class="citation audio-visual"><a class="external text" href="https://www.youtube.com/channel/UC8gjB1PSXv_oAUSAQ16S0fA" rel="nofollow"><i>Martin Shkreli</i></a>. YouTube.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.btitle=Martin+Shkreli&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fwww.youtube.com%2Fchannel%2FUC8gjB1PSXv_oAUSAQ16S0fA&amp;rft.pub=YouTube&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-111">^</a></b></span> <span class="reference-text"><cite class="citation audio-visual">Shkreli, Martin (November 4, 2015). <a class="external text" href="https://www.youtube.com/watch?v=YCB6AybM4Cs" rel="nofollow"><i>Martin Shkreli Live Stream</i></a>. YouTube.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.aufirst=Martin&amp;rft.aulast=Shkreli&amp;rft.btitle=Martin+Shkreli+Live+Stream&amp;rft.date=2015-11-04&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DYCB6AybM4Cs&amp;rft.pub=YouTube&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://allhiphop.com/2015/12/16/pharm-ceo-martin-shkreli-wants-to-bail-out-bobby-shmurda-and-pay-his-defense-too/" rel="nofollow">"Pharm CEO Martin Shkreli Wants To Bail Out Bobby Shmurda And Pay His Defense Too"</a>. <i>Allhiphop</i>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Pharm+CEO+Martin+Shkreli+Wants+To+Bail+Out+Bobby+Shmurda+And+Pay+His+Defense+Too&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fallhiphop.com%2F2015%2F12%2F16%2Fpharm-ceo-martin-shkreli-wants-to-bail-out-bobby-shmurda-and-pay-his-defense-too%2F&amp;rft.jtitle=Allhiphop&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-113">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.stereogum.com/1849517/matin-shkreli-says-hell-bail-out-bobby-shmurda-hes-going-to-owe-me-one-obviously/news" rel="nofollow">"Martin Shkreli Says He'll Bail Out Bobby Shmurda: "He's Going To Owe Me One, Obviously<span style="padding-right:0.2em;">"</span>"</a>. <i>Stereogum</i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 23,</span> 2015</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli+Says+He%27ll+Bail+Out+Bobby+Shmurda%3A+%22He%27s+Going+To+Owe+Me+One%2C+Obviously%22&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.stereogum.com%2F1849517%2Fmatin-shkreli-says-hell-bail-out-bobby-shmurda-hes-going-to-owe-me-one-obviously%2Fnews&amp;rft.jtitle=Stereogum&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-Bojku2014-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-Bojku2014_114-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Bojku, Anjeza (September 2, 2014). <a class="external text" href="http://illyriapress.com/albanian-american-hosts-reception-vice-president-biden/" rel="nofollow">"Albanian–American hosts reception with Vice President Biden"</a>. <i>Illyria</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a class="external text" href="//www.worldcat.org/issn/1063-8385" rel="nofollow">1063-8385</a>. <a class="external text" href="https://web.archive.org/web/20151222100405/illyriapress.com/albanian-american-hosts-reception-vice-president-biden/" rel="nofollow">Archived</a> from the original on December 22, 2015.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Albanian%93American+hosts+reception+with+Vice+President+Biden&amp;rft.aufirst=Anjeza&amp;rft.aulast=Bojku&amp;rft.date=2014-09-02&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fillyriapress.com%2Falbanian-american-hosts-reception-vice-president-biden%2F&amp;rft.issn=1063-8385&amp;rft.jtitle=Illyria&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><cite class="citation web">Chris Isidore (19 October 2015). <a class="external text" href="http://money.cnn.com/2015/10/16/news/companies/sanders-drug-ceo-shkreli-donation" rel="nofollow">"Bernie Sanders rejects donation from most hated drug CEO"</a>. <a class="mw-redirect" href="/wiki/CNN_Money" title="CNN Money">CNN Money</a><span class="reference-accessdate">. Retrieved <span class="nowrap">12 February</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.au=Chris+Isidore&amp;rft.btitle=Bernie+Sanders+rejects+donation+from+most+hated+drug+CEO&amp;rft.date=2015-10-19&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fmoney.cnn.com%2F2015%2F10%2F16%2Fnews%2Fcompanies%2Fsanders-drug-ceo-shkreli-donation&amp;rft.pub=CNN+Money&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><a href="/wiki/Zack_O%27Malley_Greenburg" title="Zack O'Malley Greenburg">Greenburg, Zack O'Malley</a> (November 24, 2015). <a class="external text" href="http://www.forbes.com/sites/zackomalleygreenburg/2015/11/24/wu-tang-clan-secret-album-sold-by-paddle8-but-to-whom" rel="nofollow">"Wu-Tang Clan Secret Album Sold By Paddle8, But To Whom?"</a>, <i>Forbes</i>. Retrieved December 23, 2015.</span></li>
<li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="http://www.freep.com/story/entertainment/people/2016/02/12/beyonce-show-ford-field-bumped/80296354/" rel="nofollow">"Martin Shkreli makes a play for Kanye album"</a>. Detroit Free Press. 12 February 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">13 February</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli+makes+a+play+for+Kanye+album&amp;rft.date=2016-02-12&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.freep.com%2Fstory%2Fentertainment%2Fpeople%2F2016%2F02%2F12%2Fbeyonce-show-ford-field-bumped%2F80296354%2F&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text"><cite class="citation news">Deerwester, Jaime; McCoy, Kevin (12 February 2016). <a class="external text" href="http://www.usatoday.com/story/life/entertainthis/2016/02/11/martin-shkreli-offers-10m-kanyes-new-abum/80252584/" rel="nofollow">"Martin Shkreli: Kanye must take offer to record label board"</a>. USA Today<span class="reference-accessdate">. Retrieved <span class="nowrap">13 February</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli%3A+Kanye+must+take+offer+to+record+label+board&amp;rft.aufirst=Jaime&amp;rft.aulast=Deerwester&amp;rft.au=McCoy%2C+Kevin&amp;rft.date=2016-02-12&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.usatoday.com%2Fstory%2Flife%2Fentertainthis%2F2016%2F02%2F11%2Fmartin-shkreli-offers-10m-kanyes-new-abum%2F80252584%2F&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="http://hiphopdx.com/news/id.37456/title.martin-shkreli-offers-to-buy-kanye-wests-the-life-of-pablo-for-10-million" rel="nofollow">"Martin Shkreli Increases Offer To Buy Kanye West's "The Life Of Pablo" To $15 Million"</a>. HipHopDX. 12 February 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">14 February</span> 2016</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli+Increases+Offer+To+Buy+Kanye+West%99s+%22The+Life+Of+Pablo%22+To+%2415+Million&amp;rft.date=2016-02-12&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fhiphopdx.com%2Fnews%2Fid.37456%2Ftitle.martin-shkreli-offers-to-buy-kanye-wests-the-life-of-pablo-for-10-million&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><a class="external free" href="http://www.xxlmag.com/news/2016/10/martin-shkreli-unreleased-wu-tang-clan-donald-trump-wins-election/" rel="nofollow">http://www.xxlmag.com/news/2016/10/martin-shkreli-unreleased-wu-tang-clan-donald-trump-wins-election/</a></span></li>
<li id="cite_note-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-121">^</a></b></span> <span class="reference-text"><a class="external text" href="http://gizmodo.com/hell-freezes-over-as-martin-shkreli-performs-a-public-s-1788765726" rel="nofollow">Hell Freezes Over as Martin Shkreli Performs a Public Service</a> Gizmodo, November 9, 2016</span></li>
<li id="cite_note-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-122">^</a></b></span> <span class="reference-text"><cite class="citation web">CNBC (2017-01-08). <a class="external text" href="http://www.cnbc.com/2017/01/08/martin-shkreli-has-been-suspended-from-twitter.html" rel="nofollow">"Martin Shkreli trolls Teen Vogue reporter, gets suspended from Twitter"</a>. <i>CNBC</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2017-01-08</span></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli+trolls+Teen+Vogue+reporter%2C+gets+suspended+from+Twitter&amp;rft.au=CNBC&amp;rft.date=2017-01-08&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.cnbc.com%2F2017%2F01%2F08%2Fmartin-shkreli-has-been-suspended-from-twitter.html&amp;rft.jtitle=CNBC&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-123">^</a></b></span> <span class="reference-text"><cite class="citation news"><a class="external text" href="http://www.businessinsider.com/martin-shkreli-suspended-twitter-harassing-female-journalist-lauren-duca-2017-1" rel="nofollow">"Martin Shkreli suspended from Twitter for harassing freelance journalist Lauren Duca"</a>. <i>Business Insider</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2017-01-08</span></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.atitle=Martin+Shkreli+suspended+from+Twitter+for+harassing+freelance+journalist+Lauren+Duca&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.businessinsider.com%2Fmartin-shkreli-suspended-twitter-harassing-female-journalist-lauren-duca-2017-1&amp;rft.jtitle=Business+Insider&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal"><span style="display:none;"> </span></span></span></li>
<li id="cite_note-clover-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-clover_124-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a class="external text" href="http://www.snopes.com/are-people-identifying-as-clovergender/" rel="nofollow">"Cloverfailed"</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMartin+Shkreli&amp;rft.btitle=Cloverfailed&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.snopes.com%2Fare-people-identifying-as-clovergender%2F&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook"><span style="display:none;"> </span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span></h2>
<ul>
<li><a class="external text" href="https://twitter.com/MartinShkreli" rel="nofollow">Martin Shkreli</a> on <a href="/wiki/Twitter" title="Twitter">Twitter</a> <a href="https://www.wikidata.org/wiki/Q6776585#P2002" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" data-file-height="600" data-file-width="600" height="10" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/10px-Blue_pencil.svg.png" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/15px-Blue_pencil.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/20px-Blue_pencil.svg.png 2x" style="vertical-align: text-top" width="10"/></a></li>
<li><a class="external text" href="https://www.youtube.com/channel/UC8gjB1PSXv_oAUSAQ16S0fA" rel="nofollow"><span class="plainlinks">Martin Shkreli</span>'s channel</a> on <a href="/wiki/YouTube" title="YouTube">YouTube</a></li>
<li><a class="external text" href="https://www.youtube.com/watch?v=YCB6AybM4Cs" rel="nofollow"><span class="plainlinks">Martin Shkreli Live Stream</span></a> on <a href="/wiki/YouTube" title="YouTube">YouTube</a></li>
<li><a class="external text" href="https://www.youtube.com/watch?v=2PCb9mnrU1g" rel="nofollow"><span class="plainlinks">29 Jan 2016 Vice Interview</span></a> on <a href="/wiki/YouTube" title="YouTube">YouTube</a></li>
</ul>
<!-- 
NewPP limit report
Parsed by mw1246
Cached time: 20170127103934
Cache expiry: 3600
Dynamic content: true
CPU time usage: 0.808 seconds
Real time usage: 0.897 seconds
Preprocessor visited node count: 7151/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 222985/2097152 bytes
Template argument size: 4941/2097152 bytes
Highest expansion depth: 16/40
Expensive parser function count: 8/500
Lua time usage: 0.438/10.000 seconds
Lua memory usage: 6.9 MB/50 MB
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  830.753      1 -total
 59.42%  493.614      1 Template:Reflist
 35.50%  294.909     89 Template:Cite_web
  8.51%   70.701      1 Template:Infobox_person
  7.06%   58.641     18 Template:Cite_news
  6.95%   57.736      1 Template:Pp-blp
  5.67%   47.068      3 Template:Fix
  5.07%   42.124      1 Template:Infobox
  4.90%   40.746      2 Template:Fact
  2.88%   23.959      3 Template:Delink
-->
<!-- Saved in parser cache with key enwiki:pcache:idhash:33759585-0!*!0!!en!4!* and timestamp 20170127103933 and revision id 762047050
 -->
<noscript><img alt="" height="1" src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" style="border: none; position: absolute;" title="" width="1"/></noscript></div> <div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Martin_Shkreli&amp;oldid=762047050">https://en.wikipedia.org/w/index.php?title=Martin_Shkreli&amp;oldid=762047050</a>"					</div>
<div class="catlinks" data-mw="interface" id="catlinks"><div class="mw-normal-catlinks" id="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:1983_births" title="Category:1983 births">1983 births</a></li><li><a href="/wiki/Category:2015_controversies" title="Category:2015 controversies">2015 controversies</a></li><li><a href="/wiki/Category:American_chief_executives" title="Category:American chief executives">American chief executives</a></li><li><a href="/wiki/Category:American_hedge_fund_managers" title="Category:American hedge fund managers">American hedge fund managers</a></li><li><a href="/wiki/Category:American_people_of_Albanian_descent" title="Category:American people of Albanian descent">American people of Albanian descent</a></li><li><a href="/wiki/Category:American_people_of_Croatian_descent" title="Category:American people of Croatian descent">American people of Croatian descent</a></li><li><a href="/wiki/Category:Baruch_College_alumni" title="Category:Baruch College alumni">Baruch College alumni</a></li><li><a href="/wiki/Category:Chief_executives_in_the_pharmaceutical_industry" title="Category:Chief executives in the pharmaceutical industry">Chief executives in the pharmaceutical industry</a></li><li><a href="/wiki/Category:ESports_people" title="Category:ESports people">ESports people</a></li><li><a href="/wiki/Category:American_company_founders" title="Category:American company founders">American company founders</a></li><li><a href="/wiki/Category:Life_sciences_industry" title="Category:Life sciences industry">Life sciences industry</a></li><li><a href="/wiki/Category:Living_people" title="Category:Living people">Living people</a></li><li><a href="/wiki/Category:People_from_Brooklyn" title="Category:People from Brooklyn">People from Brooklyn</a></li><li><a href="/wiki/Category:Wealth_in_the_United_States" title="Category:Wealth in the United States">Wealth in the United States</a></li><li><a href="/wiki/Category:Pricing_controversies" title="Category:Pricing controversies">Pricing controversies</a></li></ul></div><div class="mw-hidden-catlinks mw-hidden-cats-hidden" id="mw-hidden-catlinks">Hidden categories: <ul><li><a href="/wiki/Category:Pages_containing_links_to_subscription-only_content" title="Category:Pages containing links to subscription-only content">Pages containing links to subscription-only content</a></li><li><a href="/wiki/Category:Wikipedia_temporarily_semi-protected_biographies_of_living_people" title="Category:Wikipedia temporarily semi-protected biographies of living people">Wikipedia temporarily semi-protected biographies of living people</a></li><li><a href="/wiki/Category:Use_mdy_dates_from_December_2015" title="Category:Use mdy dates from December 2015">Use mdy dates from December 2015</a></li><li><a href="/wiki/Category:Pages_using_infobox_person_with_unknown_parameters" title="Category:Pages using infobox person with unknown parameters">Pages using infobox person with unknown parameters</a></li><li><a href="/wiki/Category:Infobox_person_using_ethnicity" title="Category:Infobox person using ethnicity">Infobox person using ethnicity</a></li><li><a href="/wiki/Category:Articles_with_hCards" title="Category:Articles with hCards">Articles with hCards</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_December_2015" title="Category:Articles containing potentially dated statements from December 2015">Articles containing potentially dated statements from December 2015</a></li><li><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_January_2017" title="Category:Articles with unsourced statements from January 2017">Articles with unsourced statements from January 2017</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2014" title="Category:Articles containing potentially dated statements from 2014">Articles containing potentially dated statements from 2014</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_August_2016" title="Category:Articles with unsourced statements from August 2016">Articles with unsourced statements from August 2016</a></li></ul></div></div> <div class="visualClear"></div>
</div>
</div>
<div id="mw-navigation">
<h2>Navigation menu</h2>
<div id="mw-head">
<div aria-labelledby="p-personal-label" class="" id="p-personal" role="navigation">
<h3 id="p-personal-label">Personal tools</h3>
<ul>
<li id="pt-anonuserpage">Not logged in</li><li id="pt-anontalk"><a accesskey="n" href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]">Talk</a></li><li id="pt-anoncontribs"><a accesskey="y" href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]">Contributions</a></li><li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Martin+Shkreli" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a accesskey="o" href="/w/index.php?title=Special:UserLogin&amp;returnto=Martin+Shkreli" title="You're encouraged to log in; however, it's not mandatory. [o]">Log in</a></li> </ul>
</div>
<div id="left-navigation">
<div aria-labelledby="p-namespaces-label" class="vectorTabs" id="p-namespaces" role="navigation">
<h3 id="p-namespaces-label">Namespaces</h3>
<ul>
<li class="selected" id="ca-nstab-main"><span><a accesskey="c" href="/wiki/Martin_Shkreli" title="View the content page [c]">Article</a></span></li>
<li id="ca-talk"><span><a accesskey="t" href="/wiki/Talk:Martin_Shkreli" rel="discussion" title="Discussion about the content page [t]">Talk</a></span></li>
</ul>
</div>
<div aria-labelledby="p-variants-label" class="vectorMenu emptyPortlet" id="p-variants" role="navigation">
<h3 id="p-variants-label">
<span>Variants</span><a href="#"></a>
</h3>
<div class="menu">
<ul>
</ul>
</div>
</div>
</div>
<div id="right-navigation">
<div aria-labelledby="p-views-label" class="vectorTabs" id="p-views" role="navigation">
<h3 id="p-views-label">Views</h3>
<ul>
<li class="selected" id="ca-view"><span><a href="/wiki/Martin_Shkreli">Read</a></span></li>
<li id="ca-viewsource"><span><a accesskey="e" href="/w/index.php?title=Martin_Shkreli&amp;action=edit" title="This page is protected.
You can view its source [e]">View source</a></span></li>
<li class="collapsible" id="ca-history"><span><a accesskey="h" href="/w/index.php?title=Martin_Shkreli&amp;action=history" title="Past revisions of this page [h]">View history</a></span></li>
</ul>
</div>
<div aria-labelledby="p-cactions-label" class="vectorMenu emptyPortlet" id="p-cactions" role="navigation">
<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>
<div class="menu">
<ul>
</ul>
</div>
</div>
<div id="p-search" role="search">
<h3>
<label for="searchInput">Search</label>
</h3>
<form action="/w/index.php" id="searchform">
<div id="simpleSearch">
<input accesskey="f" id="searchInput" name="search" placeholder="Search Wikipedia" title="Search Wikipedia [f]" type="search"/><input name="title" type="hidden" value="Special:Search"/><input class="searchButton mw-fallbackSearchButton" id="mw-searchButton" name="fulltext" title="Search Wikipedia for this text" type="submit" value="Search"/><input class="searchButton" id="searchButton" name="go" title="Go to a page with this exact name if it exists" type="submit" value="Go"/> </div>
</form>
</div>
</div>
</div>
<div id="mw-panel">
<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page" title="Visit the main page"></a></div>
<div aria-labelledby="p-navigation-label" class="portal" id="p-navigation" role="navigation">
<h3 id="p-navigation-label">Navigation</h3>
<div class="body">
<ul>
<li id="n-mainpage-description"><a accesskey="z" href="/wiki/Main_Page" title="Visit the main page [z]">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a accesskey="x" href="/wiki/Special:Random" title="Load a random article [x]">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikipedia store">Wikipedia store</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-interaction-label" class="portal" id="p-interaction" role="navigation">
<h3 id="p-interaction-label">Interaction</h3>
<div class="body">
<ul>
<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a accesskey="r" href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact page</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-tb-label" class="portal" id="p-tb" role="navigation">
<h3 id="p-tb-label">Tools</h3>
<div class="body">
<ul>
<li id="t-whatlinkshere"><a accesskey="j" href="/wiki/Special:WhatLinksHere/Martin_Shkreli" title="List of all English Wikipedia pages containing links to this page [j]">What links here</a></li><li id="t-recentchangeslinked"><a accesskey="k" href="/wiki/Special:RecentChangesLinked/Martin_Shkreli" rel="nofollow" title="Recent changes in pages linked from this page [k]">Related changes</a></li><li id="t-upload"><a accesskey="u" href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]">Upload file</a></li><li id="t-specialpages"><a accesskey="q" href="/wiki/Special:SpecialPages" title="A list of all special pages [q]">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Martin_Shkreli&amp;oldid=762047050" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Martin_Shkreli&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a accesskey="g" href="https://www.wikidata.org/wiki/Q6776585" title="Link to connected data repository item [g]">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Martin_Shkreli&amp;id=762047050" title="Information on how to cite this page">Cite this page</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-coll-print_export-label" class="portal" id="p-coll-print_export" role="navigation">
<h3 id="p-coll-print_export-label">Print/export</h3>
<div class="body">
<ul>
<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Martin+Shkreli">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Martin+Shkreli&amp;returnto=Martin+Shkreli&amp;oldid=762047050&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a accesskey="p" href="/w/index.php?title=Martin_Shkreli&amp;printable=yes" title="Printable version of this page [p]">Printable version</a></li> </ul>
</div>
</div>
<div aria-labelledby="p-lang-label" class="portal" id="p-lang" role="navigation">
<h3 id="p-lang-label">Languages</h3>
<div class="body">
<ul>
<li class="interlanguage-link interwiki-am"><a class="interlanguage-link-target" href="https://am.wikipedia.org/wiki/%E1%88%9B%E1%88%AD%E1%89%B2%E1%8A%95_%E1%88%BD%E1%8A%AD%E1%88%A8%E1%88%8A" hreflang="am" lang="am" title="ማርቲን ሽክረሊ – Amharic">አማርኛ</a></li><li class="interlanguage-link interwiki-ar"><a class="interlanguage-link-target" href="https://ar.wikipedia.org/wiki/%D9%85%D8%A7%D8%B1%D8%AA%D9%86_%D8%B4%D9%83%D8%B1%D9%8A%D9%84%D9%8A" hreflang="ar" lang="ar" title="مارتن شكريلي – Arabic">العربية</a></li><li class="interlanguage-link interwiki-azb"><a class="interlanguage-link-target" href="https://azb.wikipedia.org/wiki/%D9%85%D8%A7%D8%B1%D8%AA%DB%8C%D9%86_%D8%B4%DA%A9%D8%B1%D8%A6%D9%84%DB%8C" hreflang="azb" lang="azb" title="مارتین شکرئلی – تۆرکجه">تۆرکجه</a></li><li class="interlanguage-link interwiki-de"><a class="interlanguage-link-target" href="https://de.wikipedia.org/wiki/Martin_Shkreli" hreflang="de" lang="de" title="Martin Shkreli – German">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a class="interlanguage-link-target" href="https://es.wikipedia.org/wiki/Martin_Shkreli" hreflang="es" lang="es" title="Martin Shkreli – Spanish">Español</a></li><li class="interlanguage-link interwiki-fa"><a class="interlanguage-link-target" href="https://fa.wikipedia.org/wiki/%D9%85%D8%A7%D8%B1%D8%AA%DB%8C%D9%86_%D8%B4%DA%A9%D8%B1%D9%84%DB%8C" hreflang="fa" lang="fa" title="مارتین شکرلی – Persian">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a class="interlanguage-link-target" href="https://fr.wikipedia.org/wiki/Martin_Shkreli" hreflang="fr" lang="fr" title="Martin Shkreli – French">Français</a></li><li class="interlanguage-link interwiki-ko"><a class="interlanguage-link-target" href="https://ko.wikipedia.org/wiki/%EB%A7%88%ED%8B%B4_%EC%8A%88%ED%81%AC%EB%A0%90%EB%A6%AC" hreflang="ko" lang="ko" title="마틴 슈크렐리 – Korean">한국어</a></li><li class="interlanguage-link interwiki-nl"><a class="interlanguage-link-target" href="https://nl.wikipedia.org/wiki/Martin_Shkreli" hreflang="nl" lang="nl" title="Martin Shkreli – Dutch">Nederlands</a></li><li class="interlanguage-link interwiki-ru"><a class="interlanguage-link-target" href="https://ru.wikipedia.org/wiki/%D0%A8%D0%BA%D1%80%D0%B5%D0%BB%D0%B8,_%D0%9C%D0%B0%D1%80%D1%82%D0%B8%D0%BD" hreflang="ru" lang="ru" title="Шкрели, Мартин – Russian">Русский</a></li><li class="interlanguage-link interwiki-sq"><a class="interlanguage-link-target" href="https://sq.wikipedia.org/wiki/Martin_Shkreli" hreflang="sq" lang="sq" title="Martin Shkreli – Albanian">Shqip</a></li><li class="interlanguage-link interwiki-uk"><a class="interlanguage-link-target" href="https://uk.wikipedia.org/wiki/%D0%9C%D0%B0%D1%80%D1%82%D1%96%D0%BD_%D0%A8%D0%BA%D1%80%D0%B5%D0%BB%D1%96" hreflang="uk" lang="uk" title="Мартін Шкрелі – Ukrainian">Українська</a></li> </ul>
<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a class="wbc-editpage" href="https://www.wikidata.org/wiki/Q6776585#sitelinks-wikipedia" title="Edit interlanguage links">Edit links</a></span></div> </div>
</div>
</div>
</div>
<div id="footer" role="contentinfo">
<ul id="footer-info">
<li id="footer-info-lastmod"> This page was last modified on 26 January 2017, at 09:05.</li>
<li id="footer-info-copyright">Text is available under the <a href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License" rel="license">Creative Commons Attribution-ShareAlike License</a><a href="//creativecommons.org/licenses/by-sa/3.0/" rel="license" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>
<ul id="footer-places">
<li id="footer-places-privacy"><a class="extiw" href="https://wikimediafoundation.org/wiki/Privacy_policy" title="wmf:Privacy policy">Privacy policy</a></li>
<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
<li id="footer-places-cookiestatement"><a href="https://wikimediafoundation.org/wiki/Cookie_statement">Cookie statement</a></li>
<li id="footer-places-mobileview"><a class="noprint stopMobileRedirectToggle" href="//en.m.wikipedia.org/w/index.php?title=Martin_Shkreli&amp;mobileaction=toggle_view_mobile">Mobile view</a></li>
</ul>
<ul class="noprint" id="footer-icons">
<li id="footer-copyrightico">
<a href="https://wikimediafoundation.org/"><img alt="Wikimedia Foundation" height="31" src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88"/></a> </li>
<li id="footer-poweredbyico">
<a href="//www.mediawiki.org/"><img alt="Powered by MediaWiki" height="31" src="/static/images/poweredby_mediawiki_88x31.png" srcset="/static/images/poweredby_mediawiki_132x47.png 1.5x, /static/images/poweredby_mediawiki_176x62.png 2x" width="88"/></a> </li>
</ul>
<div style="clear:both"></div>
</div>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.808","walltime":"0.897","ppvisitednodes":{"value":7151,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":222985,"limit":2097152},"templateargumentsize":{"value":4941,"limit":2097152},"expansiondepth":{"value":16,"limit":40},"expensivefunctioncount":{"value":8,"limit":500},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00%  830.753      1 -total"," 59.42%  493.614      1 Template:Reflist"," 35.50%  294.909     89 Template:Cite_web","  8.51%   70.701      1 Template:Infobox_person","  7.06%   58.641     18 Template:Cite_news","  6.95%   57.736      1 Template:Pp-blp","  5.67%   47.068      3 Template:Fix","  5.07%   42.124      1 Template:Infobox","  4.90%   40.746      2 Template:Fact","  2.88%   23.959      3 Template:Delink"]},"scribunto":{"limitreport-timeusage":{"value":"0.438","limit":"10.000"},"limitreport-memusage":{"value":7234961,"limit":52428800}},"cachereport":{"origin":"mw1246","timestamp":"20170127103934","ttl":3600,"transientcontent":true}}});});</script><script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":967,"wgHostname":"mw1246"});});</script>
</body>
</html>
